chr	coordinate	gene_symbol+nt_change	gene_symbol	nt_change	hgnc_id	aa_change	doid	disease_name	drug_name
chr1	8013449	ERRFI1 C>A	ERRFI1	C>A	691	E384*	4947	Cholangiocarcinoma	Erlotinib
chr1	11117039	MTOR C>A	MTOR	C>A	609	M2327I	1612	Breast Cancer	RapaLink-1
chr1	11117039	MTOR C>A	MTOR	C>A	609	M2327I	1612	Breast Cancer	Sirolimus
chr1	11117039	MTOR C>A	MTOR	C>A	609	M2327I	1612	Breast Cancer	MTOR Kinase Inhibitor AZD8055
chr1	11124516	MTOR G>T	MTOR	G>T	542	S2215Y	2870	Endometrial Adenocarcinoma	Sirolimus
chr1	11124523	MTOR G>A	MTOR	G>A	284	P2213S	1909	Melanoma	PI3K/BET Inhibitor LY294002
chr1	11124523	MTOR G>A	MTOR	G>A	284	P2213S	1909	Melanoma	Capivasertib
chr1	11127037	MTOR G>T	MTOR	G>T	470	F2108L	1612	Breast Cancer	Everolimus
chr1	11127037	MTOR G>T	MTOR	G>T	470	F2108L	1612	Breast Cancer	Sirolimus
chr1	11127739	MTOR G>A	MTOR	G>A	610	A2034V	1612	Breast Cancer	RapaLink-1
chr1	11127739	MTOR G>A	MTOR	G>A	610	A2034V	1612	Breast Cancer	Sirolimus
chr1	11127739	MTOR G>A	MTOR	G>A	610	A2034V	1612	Breast Cancer	MTOR Kinase Inhibitor AZD8055
chr1	11127800	MTOR C>T	MTOR	C>T	572	E2014K	2671	Transitional Cell Carcinoma	Everolimus
chr1	11127800	MTOR C>T	MTOR	C>T	572	E2014K	2671	Transitional Cell Carcinoma	Pazopanib
chr1	11128462	MTOR G>A	MTOR	G>A	283	H1968Y	1909	Melanoma	PI3K/BET Inhibitor LY294002
chr1	11128462	MTOR G>A	MTOR	G>A	283	H1968Y	1909	Melanoma	Capivasertib
chr1	11130747	MTOR C>T	MTOR	C>T	544	E1799K	4467	Clear Cell Renal Cell Carcinoma	Sirolimus
chr1	11157173	MTOR C>T	MTOR	C>T	543	C1483Y	5603	T-cell Acute Lymphoblastic Leukemia	Sirolimus
chr1	11796321	MTHFR G>A	MTHFR	G>A	258	A222V	1993	Rectum Cancer	Fluorouracil
chr1	26731167	ARID1A C>T	ARID1A	C>T	1510	Q456*	9256	Colorectal Cancer	Dasatinib
chr1	36467833	CSF3R G>A	CSF3R	G>A	2387	T618I	0080187	Chronic Neutrophilic Leukemia	Ruxolitinib
chr1	64845520	JAK1 C>A	JAK1	C>A	822	S703I	684	Hepatocellular Carcinoma	Ruxolitinib
chr1	64855650	JAK1 G>A	JAK1	G>A	614	Q503*	8923	Skin Melanoma	Pembrolizumab
chr1	67686705	GADD45A T>C	GADD45A	T>C	705	rs681673	2394	Ovarian Cancer	""
chr1	64855650	JAK1 G>A	JAK1	G>A	614	Q503*	8923	Skin Melanoma	Pembrolizumab
chr1	97450058	DPYD C>T	DPYD	C>T	737	DPYD*2A	162	Cancer	Fluorouracil
chr1	97450058	DPYD C>T	DPYD	C>T	737	DPYD*2A	162	Cancer	Tegafur
chr1	97450058	DPYD C>T	DPYD	C>T	737	DPYD*2A	162	Cancer	Capecitabine
chr1	97515787	DPYD A>C	DPYD	A>C	738	DPYD*13	162	Cancer	Fluorouracil
chr1	97515787	DPYD A>C	DPYD	A>C	738	DPYD*13	162	Cancer	Tegafur
chr1	97515787	DPYD A>C	DPYD	A>C	738	DPYD*13	162	Cancer	Capecitabine
chr1	114713907	NRAS T>G	NRAS	T>G	893	Q61H	9256	Colorectal Cancer	Cetuximab
chr1	114713907	NRAS T>G	NRAS	T>G	893	Q61H	9256	Colorectal Cancer	Irinotecan
chr1	114713908	NRAS T>C	NRAS	T>C	96	Q61R	9256	Colorectal Cancer	Cetuximab
chr1	114713908	NRAS T>C	NRAS	T>C	96	Q61R	9256	Colorectal Cancer	Temozolomide
chr1	114713908	NRAS T>A	NRAS	T>A	95	Q61L	9256	Colorectal Cancer	Cetuximab
chr1	114713908	NRAS T>A	NRAS	T>A	95	Q61L	9256	Colorectal Cancer	Temozolomide
chr1	114713908	NRAS T>A	NRAS	T>A	95	Q61L	9256	Colorectal Cancer	Irinotecan
chr1	114713909	NRAS G>T	NRAS	G>T	427	Q61K	9256	Colorectal Cancer	Binimetinib
chr1	114713909	NRAS G>T	NRAS	G>T	427	Q61K	9256	Colorectal Cancer	Vemurafenib
chr1	114713909	NRAS G>T	NRAS	G>T	427	Q61K	9256	Colorectal Cancer	Trametinib
chr1	114713909	NRAS G>T	NRAS	G>T	427	Q61K	9256	Colorectal Cancer	Everolimus
chr1	114713909	NRAS G>T	NRAS	G>T	427	Q61K	9256	Colorectal Cancer	Cetuximab
chr1	114713909	NRAS G>T	NRAS	G>T	427	Q61K	9256	Colorectal Cancer	Chemotherapy
chr1	114713909	NRAS G>T	NRAS	G>T	427	Q61K	9256	Colorectal Cancer	Dactolisib
chr1	114713909	NRAS G>T	NRAS	G>T	427	Q61K	9256	Colorectal Cancer	Selumetinib
chr1	114716123	NRAS C>T	NRAS	C>T	93	G13D	1909	Melanoma	Tanespimycin
chr1	114716124	NRAS C>G	NRAS	C>G	896	G13R	9256	Colorectal Cancer	Cetuximab
chr1	114716124	NRAS C>G	NRAS	C>G	896	G13R	9256	Colorectal Cancer	Panitumumab
chr1	114716124	NRAS C>G	NRAS	C>G	896	G13R	9256	Colorectal Cancer	Irinotecan
chr1	114716126	NRAS C>T	NRAS	C>T	878	G12D	9256	Colorectal Cancer	Cetuximab
chr1	114716126	NRAS C>T	NRAS	C>T	878	G12D	9256	Colorectal Cancer	Irinotecan
chr1	114716127	NRAS C>A	NRAS	C>A	897	G12C	9256	Colorectal Cancer	Cetuximab
chr1	114716127	NRAS C>A	NRAS	C>A	897	G12C	9256	Colorectal Cancer	Chemotherapy
chr1	161509955	FCGR2A A>G	FCGR2A	A>G	456	H167R	1612	Breast Cancer	Trastuzumab
chr1	161544752	FCGR3A A>C	FCGR3A	A>C	457	F212V	1612	Breast Cancer	Trastuzumab
chr1	161674008	FCGR2B T>C	FCGR2B	T>C	458	I232T	1612	Breast Cancer	""
chr1	161544752	FCGR3A A>C	FCGR3A	A>C	457	F212V	1612	Breast Cancer	Trastuzumab
chr1	162754625	DDR2 C>G	DDR2	C>G	139	L63V	3908	Lung Non-small Cell Carcinoma	Dasatinib
chr1	162759840	DDR2 T>G	DDR2	T>G	140	L239R	3908	Lung Non-small Cell Carcinoma	Dasatinib
chr1	162759881	DDR2 G>T	DDR2	G>T	141	G253C	3908	Lung Non-small Cell Carcinoma	Dasatinib
chr1	162772032	DDR2 G>A	DDR2	G>A	142	G505S	3908	Lung Non-small Cell Carcinoma	Dasatinib
chr1	162775707	DDR2 A>T	DDR2	A>T	143	I638F	3908	Lung Non-small Cell Carcinoma	Dasatinib
chr1	162778600	DDR2 T>A	DDR2	T>A	145	S768R	3908	Lung Non-small Cell Carcinoma	Dasatinib
chr1	162778600	DDR2 T>A	DDR2	T>A	145	S768R	3908	Lung Non-small Cell Carcinoma	Erlotinib
chr1	162778617	DDR2 G>T	DDR2	G>T	144	G774V	3908	Lung Non-small Cell Carcinoma	Dasatinib
chr1	226064434	H3-3A A>T	H3-3A	A>T	2416	K28M	0080684	Diffuse Midline Glioma&#44; H3 K27M-mutant	Dordaviprone
chr1	243695714	AKT3 C>T	AKT3	C>T	1227	E17K	1909	Melanoma	Vemurafenib
chr2	29209798	ALK C>T	ALK	C>T	9	R1275Q	769	Neuroblastoma	Crizotinib
chr2	29209798	ALK C>T	ALK	C>T	9	R1275Q	769	Neuroblastoma	Lorlatinib
chr2	29209798	ALK C>T	ALK	C>T	9	R1275Q	769	Neuroblastoma	TAE684
chr2	29209816	ALK C>G	ALK	C>G	308	G1269A	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	29209816	ALK C>G	ALK	C>G	308	G1269A	3908	Lung Non-small Cell Carcinoma	Brigatinib
chr2	29209816	ALK C>G	ALK	C>G	308	G1269A	3908	Lung Non-small Cell Carcinoma	Ceritinib
chr2	29209816	ALK C>G	ALK	C>G	308	G1269A	3908	Lung Non-small Cell Carcinoma	Alectinib
chr2	29213993	ALK A>C	ALK	A>C	549	F1245C	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	29213993	ALK A>C	ALK	A>C	549	F1245C	3908	Lung Non-small Cell Carcinoma	Lorlatinib
chr2	29213993	ALK A>C	ALK	A>C	549	F1245C	3908	Lung Non-small Cell Carcinoma	Ceritinib
chr2	29213994	ALK A>C	ALK	A>C	1295	F1245V	769	Neuroblastoma	Entrectinib
chr2	29220734	ALK G>T	ALK	G>T	172	S1206Y	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	29220734	ALK G>T	ALK	G>T	172	S1206Y	3908	Lung Non-small Cell Carcinoma	Ceritinib
chr2	29220747	ALK C>T	ALK	C>T	171	G1202R	3910	Lung Adenocarcinoma	Crizotinib
chr2	29220747	ALK C>T	ALK	C>T	171	G1202R	3910	Lung Adenocarcinoma	Tanespimycin
chr2	29220747	ALK C>T	ALK	C>T	171	G1202R	3910	Lung Adenocarcinoma	Brigatinib
chr2	29220747	ALK C>T	ALK	C>T	171	G1202R	3910	Lung Adenocarcinoma	Ceritinib
chr2	29220747	ALK C>T	ALK	C>T	171	G1202R	3910	Lung Adenocarcinoma	Alectinib
chr2	29220747	ALK C>T	ALK	C>T	171	G1202R	3910	Lung Adenocarcinoma	Lorlatinib
chr2	29220759	ALK G>A	ALK	G>A	1275	L1198F	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	29220759	ALK G>A	ALK	G>A	1275	L1198F	3908	Lung Non-small Cell Carcinoma	Lorlatinib
chr2	29220765	ALK G>T	ALK	G>T	4324	L1196M	3910	Lung Adenocarcinoma	Crizotinib
chr2	29220765	ALK G>T	ALK	G>T	4324	L1196M	3910	Lung Adenocarcinoma	Ceritinib
chr2	29220765	ALK G>T	ALK	G>T	4324	L1196M	3910	Lung Adenocarcinoma	Alectinib
chr2	29220765	ALK G>T	ALK	G>T	4324	L1196M	3910	Lung Adenocarcinoma	Lorlatinib
chr2	29220813	ALK C>G	ALK	C>G	528	V1180L	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	29220813	ALK C>G	ALK	C>G	528	V1180L	3908	Lung Non-small Cell Carcinoma	Brigatinib
chr2	29220813	ALK C>G	ALK	C>G	528	V1180L	3908	Lung Non-small Cell Carcinoma	Ceritinib
chr2	29220813	ALK C>G	ALK	C>G	528	V1180L	3908	Lung Non-small Cell Carcinoma	Alectinib
chr2	29220813	ALK C>G	ALK	C>G	528	V1180L	3908	Lung Non-small Cell Carcinoma	TAE684
chr2	29220829	ALK G>T	ALK	G>T	8	F1174L	0050905	Inflammatory Myofibroblastic Tumor	Crizotinib
chr2	29220829	ALK G>T	ALK	G>T	8	F1174L	0050905	Inflammatory Myofibroblastic Tumor	AZD3463
chr2	29220829	ALK G>T	ALK	G>T	8	F1174L	0050905	Inflammatory Myofibroblastic Tumor	Alectinib
chr2	29220829	ALK G>T	ALK	G>T	8	F1174L	0050905	Inflammatory Myofibroblastic Tumor	Lorlatinib
chr2	29220829	ALK G>T	ALK	G>T	8	F1174L	0050905	Inflammatory Myofibroblastic Tumor	TAE684
chr2	29222347	ALK A>C	ALK	A>C	589	I1171S	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	29222347	ALK A>C	ALK	A>C	589	I1171S	3908	Lung Non-small Cell Carcinoma	Alectinib
chr2	29222347	ALK A>T	ALK	A>T	588	I1171N	7474	Malignant Pleural Mesothelioma	Crizotinib
chr2	29222347	ALK A>T	ALK	A>T	588	I1171N	7474	Malignant Pleural Mesothelioma	Alectinib
chr2	29222347	ALK A>T	ALK	A>T	588	I1171N	7474	Malignant Pleural Mesothelioma	Lorlatinib
chr2	29222347	ALK A>G	ALK	A>G	527	I1171	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	29222347	ALK A>G	ALK	A>G	527	I1171	3908	Lung Non-small Cell Carcinoma	Ceritinib
chr2	29222347	ALK A>G	ALK	A>G	527	I1171	3908	Lung Non-small Cell Carcinoma	Alectinib
chr2	29222347	ALK A>G	ALK	A>G	527	I1171	3908	Lung Non-small Cell Carcinoma	TAE684
chr2	29222392	ALK C>T	ALK	C>T	4331	C1156Y	3910	Lung Adenocarcinoma	Crizotinib
chr2	29222392	ALK C>T	ALK	C>T	4331	C1156Y	3910	Lung Adenocarcinoma	Ceritinib
chr2	29222392	ALK C>T	ALK	C>T	4331	C1156Y	3910	Lung Adenocarcinoma	Lorlatinib
chr2	29222392	ALK C>T	ALK	C>T	4331	C1156Y	3910	Lung Adenocarcinoma	Luminespib
chr2	29222404	ALK A>C	ALK	A>C	307	L1152R	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	47410241	MSH2 A>T	MSH2	A>T	770	K172*	9256	Colorectal Cancer	""
chr2	29222404	ALK A>C	ALK	A>C	307	L1152R	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	47429812	MSH2 C>T	MSH2	C>T	727	R383*	1380	Endometrial Cancer	""
chr2	29222404	ALK A>C	ALK	A>C	307	L1152R	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	47463092	MSH2 A>G	MSH2	A>G	773	E483G	1380	Endometrial Cancer	""
chr2	29222404	ALK A>C	ALK	A>C	307	L1152R	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	47791078	MSH6 C>A	MSH6	C>A	761	P138T	9256	Colorectal Cancer	""
chr2	29222404	ALK A>C	ALK	A>C	307	L1152R	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	47799037	MSH6 G>A	MSH6	G>A	775	V352I	1380	Endometrial Cancer	""
chr2	29222404	ALK A>C	ALK	A>C	307	L1152R	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	47806281	MSH6 C>T	MSH6	C>T	776	R1242C	9256	Colorectal Cancer	""
chr2	29222404	ALK A>C	ALK	A>C	307	L1152R	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	47806282	MSH6 G>A	MSH6	G>A	767	R1242H	9256	Colorectal Cancer	""
chr2	29222404	ALK A>C	ALK	A>C	307	L1152R	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	157766004	ACVR1 C>A	ACVR1	C>A	1686	G328V	80684	Diffuse Midline Glioma&#44; H3 K27M-mutant	""
chr2	29222404	ALK A>C	ALK	A>C	307	L1152R	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	157766005	ACVR1 C>A	ACVR1	C>A	2280	G328W	0080684	Diffuse Midline Glioma&#44; H3 K27M-mutant	""
chr2	29222404	ALK A>C	ALK	A>C	307	L1152R	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr2	197402635	SF3B1 C>A	SF3B1	C>A	114	K666N	1612	Breast Cancer	Spliceostatin A
chr2	201284866	CASP8 G>C	CASP8	G>C	650	D302H	769	Neuroblastoma	""
chr2	197402635	SF3B1 C>A	SF3B1	C>A	114	K666N	1612	Breast Cancer	Spliceostatin A
chr2	208248388	IDH1 C>A	IDH1	C>A	880	R132L	0080829	Low Grade Glioma	Vorasidenib
chr2	208248388	IDH1 C>T	IDH1	C>T	420	R132H	0080829	Low Grade Glioma	Vorasidenib
chr2	208248388	IDH1 C>T	IDH1	C>T	420	R132H	0080829	Low Grade Glioma	AGI-5198
chr2	208248388	IDH1 C>T	IDH1	C>T	420	R132H	0080829	Low Grade Glioma	Ivosidenib
chr2	208248389	IDH1 G>T	IDH1	G>T	928	R132S	0080829	Low Grade Glioma	Vorasidenib
chr2	208248389	IDH1 G>C	IDH1	G>C	927	R132G	0080829	Low Grade Glioma	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10141850	VHL G>A	VHL	G>A	848	M1?	4467	Clear Cell Renal Cell Carcinoma	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10141866	VHL A>G	VHL	A>G	849	N7D	4450	Renal Cell Carcinoma	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10141871	VHL G>A	VHL	G>A	1294	W8*	4450	Renal Cell Carcinoma	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10141921	VHL C>T	VHL	C>T	850	P25L	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10141983	VHL G>T	VHL	G>T	1733	E46*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142001	VHL G>A	VHL	G>A	1734	E52K	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142010	VHL G>T	VHL	G>T	1736	E55*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142012	VHL G>A	VHL	G>A	794	E55=	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142038	VHL G>C	VHL	G>C	1867	R64P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142040	VHL T>G	VHL	T>G	2011	S65A	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142040	VHL T>C	VHL	T>C	1903	S65P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142041	VHL C>A	VHL	C>A	1811	S65*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142041	VHL C>T	VHL	C>T	1788	S65L	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142041	VHL C>G	VHL	C>G	1787	S65W	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142049	VHL T>C	VHL	T>C	1873	S68P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142050	VHL C>G	VHL	C>G	2012	S68W	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142055	VHL G>A	VHL	G>A	1956	E70K	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142055	VHL G>T	VHL	G>T	1834	E70*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142061	VHL T>C	VHL	T>C	1904	S72P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142064	VHL C>T	VHL	C>T	1752	Q73*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142068	VHL T>G	VHL	T>G	1999	V74G	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142074	VHL T>C	VHL	T>C	1835	F76S	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142079	VHL A>C	VHL	A>C	1754	N78H	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142080	VHL A>T	VHL	A>T	2037	N78I	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142080	VHL A>C	VHL	A>C	1756	N78T	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142083	VHL G>C	VHL	G>C	1791	R79P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142085	VHL A>C	VHL	A>C	1963	S80R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142086	VHL G>A	VHL	G>A	1874	S80N	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142086	VHL G>T	VHL	G>T	1757	S80I	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142087	VHL T>G	VHL	T>G	1792	S80R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142088	VHL C>T	VHL	C>T	1837	P81S	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142092	VHL G>C	VHL	G>C	1980	R82P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142097	VHL G>A	VHL	G>A	2101	V84M	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142097	VHL G>T	VHL	G>T	1815	V84L	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142101	VHL T>C	VHL	T>C	2020	L85P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142103	VHL C>T	VHL	C>T	1902	P86S	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142103	VHL C>G	VHL	C>G	1759	P86A	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142104	VHL C>G	VHL	C>G	1849	P86R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142104	VHL C>T	VHL	C>T	1760	P86L	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142109	VHL T>C	VHL	T>C	2056	W88R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142109	VHL T>A	VHL	T>A	1761	W88R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142110	VHL G>A	VHL	G>A	2151	W88*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142112	VHL GGC>TT	VHL	GGC>TT	2039	W88FS	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142110	VHL G>C	VHL	G>C	1966	W88S	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142111	VHL G>A	VHL	G>A	1908	W88*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142113	VHL T>C	VHL	T>C	1793	L89P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142120	VHL C>G	VHL	C>G	2294	F91L	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142122	VHL A>G	VHL	A>G	2449	D92G	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142124	VHL G>T	VHL	G>T	2008	G93C	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142124	VHL G>C	VHL	G>C	1920	G93R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142124	VHL G>A	VHL	G>A	1859	G93S	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142125	VHL G>T	VHL	G>T	2009	G93V	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142125	VHL G>A	VHL	G>A	1858	G93D	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142127	VHL G>T	VHL	G>T	1794	E94*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142133	VHL C>T	VHL	C>T	1848	Q96*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142139	VHL T>C	VHL	T>C	1741	Y98H	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142140	VHL A>G	VHL	A>G	1933	Y98C	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142149	VHL CT>GG	VHL	CT>GG	1838	L101G	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142158	VHL G>T	VHL	G>T	2428	G104V	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142158	VHL G>C	VHL	G>C	2043	G104A	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142159	VHL C>G	VHL	C>G	2293	G104=	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142160	VHL A>C	VHL	A>C	1839	T105P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142166	VHL C>G	VHL	C>G	2007	R107G	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142167	VHL G>A	VHL	G>A	2044	R107H	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142167	VHL G>C	VHL	G>C	1840	R107P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142178	VHL CA>TT	VHL	CA>TT	1853	S111C	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142178	VHL A>T	VHL	A>T	2045	S111C	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142179	VHL G>A	VHL	G>A	1763	S111N	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142180	VHL C>G	VHL	C>G	1764	S111R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142181	VHL T>C	VHL	T>C	1865	Y112H	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142183	VHL C>A	VHL	C>A	1766	Y112*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142184	VHL C>T	VHL	C>T	1796	R113*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142187	VHL G>A	VHL	G>A	2026	G114S	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142187	VHL G>C	VHL	G>C	1857	G114R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142187	VHL G>T	VHL	G>T	1797	G114C	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142188	VHL G>A	VHL	G>A	2114	Splice	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10142192	VHL G>C	VHL	G>C	2104	Splice	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146512	VHL A>C	VHL	A>C	2133	Splice	4450	Renal Cell Carcinoma	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146516	VHL C>T	VHL	C>T	1921	H115Y	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146517	VHL A>G	VHL	A>G	2000	H115R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146517	VHL A>C	VHL	A>C	1885	H115P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146518	VHL C>G	VHL	C>G	1957	H115Q	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146518	VHL C>A	VHL	C>A	1742	H115Q	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146519	VHL C>G	VHL	C>G	1820	L116V	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146524	VHL G>T	VHL	G>T	1767	W117C	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146526	VHL T>C	VHL	T>C	1798	L118P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146530	VHL C>G	VHL	C>G	1743	F119L	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146531	VHL A>G	VHL	A>G	1914	R120G	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146535	VHL A>G	VHL	A>G	1813	D121G	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146538	VHL GC>AT	VHL	GC>AT	2028	A122I	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146555	VHL C>T	VHL	C>T	3066	L128F	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146556	VHL T>G	VHL	T>G	1886	L128R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146559	VHL T>C	VHL	T>C	2508	L129P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146561	VHL G>C	VHL	G>C	1970	V130L	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146565	VHL A>C	VHL	A>C	2580	N131T	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146565	VHL A>G	VHL	A>G	2001	N131S	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146566	VHL C>A	VHL	C>A	1953	N131K	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146567	VHL C>T	VHL	C>T	1994	Q132*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146577	VHL T>A	VHL	T>A	1769	L135*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146580	VHL T>G	VHL	T>G	1814	F136C	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146580	VHL T>C	VHL	T>C	1801	F136S	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146585	VHL C>A	VHL	C>A	1928	P138T	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146586	VHL C>G	VHL	C>G	2440	P138R	4467	Clear Cell Renal Cell Carcinoma	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146603	VHL G>T	VHL	G>T	1850	G144*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146604	VHL G>A	VHL	G>A	2290	G144E	0050892	Adrenal Gland Pheochromocytoma	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146606	VHL C>T	VHL	C>T	1883	Q145*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146618	VHL G>A	VHL	G>A	1744	A149T	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146618	VHL G>T	VHL	G>T	820	A149S	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146622	VHL A>G	VHL	A>G	2162	N150S	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146624	VHL A>T	VHL	A>T	2150	I151F	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146625	VHL T>C	VHL	T>C	1871	I151T	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146631	VHL T>C	VHL	T>C	1923	L153P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146635	VHL A>C	VHL	A>C	1962	P154=	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146637	VHL G>C	VHL	G>C	1998	Splice	4450	Renal Cell Carcinoma	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146638	VHL T>C	VHL	T>C	2075	Splice	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10146644	VHL C>T	VHL	C>T	2292	Splice	0050892	Adrenal Gland Pheochromocytoma	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149785	VHL A>G	VHL	A>G	2078	Splice	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149785	VHL A>T	VHL	A>T	1992	Splice	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149786	VHL G>T	VHL	G>T	1990	Splice	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149786	VHL G>A	VHL	G>A	1974	Splice	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149787	VHL T>G	VHL	T>G	1934	V155G	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149787	VHL T>A	VHL	T>A	1909	V155E	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149789	VHL T>A	VHL	T>A	2013	Y156N	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149789	VHL T>G	VHL	T>G	1967	Y156D	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149790	VHL A>G	VHL	A>G	1946	Y156C	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149791	VHL T>G	VHL	T>G	1968	Y156*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149793	VHL C>T	VHL	C>T	1745	T157I	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149795	VHL C>G	VHL	C>G	1803	L158V	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149796	VHL T>C	VHL	T>C	1738	L158P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149799	VHL GAA>C	VHL	GAA>C	2137	K159fs	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149804	VHL C>A	VHL	C>A	2148	R161=	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149804	VHL C>G	VHL	C>G	1915	R161G	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149804	VHL C>T	VHL	C>T	1804	R161*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149805	VHL G>C	VHL	G>C	1855	R161P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149805	VHL G>A	VHL	G>A	1746	R161Q	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149807	VHL T>C	VHL	T>C	1772	C162R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149808	VHL G>A	VHL	G>A	1824	C162Y	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149808	VHL G>T	VHL	G>T	1773	C162F	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149809	VHL C>G	VHL	C>G	1774	C162W	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149811	VHL T>A	VHL	T>A	2033	L163H	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149813	VHL C>T	VHL	C>T	1845	Q164*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149814	VHL A>T	VHL	A>T	2079	Q164L	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149814	VHL A>G	VHL	A>G	1856	Q164R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149820	VHL T>C	VHL	T>C	2437	V166A	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149820	VHL T>A	VHL	T>A	1775	V166D	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149822	VHL C>T	VHL	C>T	1747	R167W	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149823	VHL G>C	VHL	G>C	2458	R167P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149823	VHL G>T	VHL	G>T	1916	R167L	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149823	VHL G>A	VHL	G>A	1739	R167Q	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149829	VHL T>C	VHL	T>C	1887	L169P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149831	VHL G>T	VHL	G>T	1806	V170F	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149832	VHL T>G	VHL	T>G	1935	V170G	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149832	VHL T>A	VHL	T>A	1826	V170D	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149846	VHL T>A	VHL	T>A	2066	Y175N	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149846	VHL T>G	VHL	T>G	1846	Y175D	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149848	VHL C>G	VHL	C>G	1969	Y175*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149848	VHL C>A	VHL	C>A	1932	Y175*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149852	VHL A>T	VHL	A>T	1827	R177*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149856	VHL T>A	VHL	T>A	1997	L178Q	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149856	VHL T>G	VHL	T>G	1888	L178R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149856	VHL T>C	VHL	T>C	1748	L178P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149861	VHL A>G	VHL	A>G	1807	I180V	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149871	VHL C>A	VHL	C>A	1784	S183*	4450	Renal Cell Carcinoma	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149874	VHL T>G	VHL	T>G	1808	L184R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149874	VHL T>C	VHL	T>C	1776	L184P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149878	VHL C>G	VHL	C>G	1809	Y185*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149879	VHL G>A	VHL	G>A	1778	E186K	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149879	VHL G>T	VHL	G>T	1777	E186*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149885	VHL C>G	VHL	C>G	1836	L188V	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149886	VHL T>G	VHL	T>G	1924	L188R	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149886	VHL T>A	VHL	T>A	1861	L188Q	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149886	VHL T>C	VHL	T>C	1852	L188P	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149906	VHL C>T	VHL	C>T	1810	Q195*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149909	VHL A>T	VHL	A>T	1913	K196*	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149916	VHL T>A	VHL	T>A	2010	L198Q	14175	Von Hippel-Lindau Disease	""
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Vorasidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	BPTES
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Temozolomide
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	AGI-5198
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Olaparib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	Ivosidenib
chr2	208248389	IDH1 G>A	IDH1	G>A	59	R132C	9119	Acute Myeloid Leukemia	GSK321
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	10149963	VHL T>G	VHL	T>G	2488	*214G	14175	Von Hippel-Lindau Disease	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	10149964	VHL G>T	VHL	G>T	1986	*214L	14175	Von Hippel-Lindau Disease	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	10149965	VHL A>T	VHL	A>T	1988	*214C	14175	Von Hippel-Lindau Disease	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	10149965	VHL A>G	VHL	A>G	1987	*214W	14175	Von Hippel-Lindau Disease	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	10149972	VHL C>G	VHL	C>G	2024	3'UTR	14175	Von Hippel-Lindau Disease	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	10150035	VHL C>A	VHL	C>A	2152	3'UTR	14175	Von Hippel-Lindau Disease	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	12591730	RAF1 T>A	RAF1	T>A	1680	R391W			""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	36993548	MLH1 A>T	MLH1	A>T	747	M1L	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	36996648	MLH1 T>C	MLH1	T>C	745	V49A	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	36996696	MLH1 G>A	MLH1	G>A	759	G65D	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	36996701	MLH1 G>A	MLH1	G>A	757	G67R	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	36996705	MLH1 T>G	MLH1	T>G	758	I68S	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	37001045	MLH1 C>T	MLH1	C>T	741	R100*	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	37004444	MLH1 C>T	MLH1	C>T	743	T117M	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	37007055	MLH1 C>T	MLH1	C>T	753	Q149*	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	37012098	MLH1 C>T	MLH1	C>T	754	R226*	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	37014545	MLH1 G>A	MLH1	G>A	731	c.790+1G>A	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	37017508	MLH1 C>G	MLH1	C>G	749	R265G	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	37025868	MLH1 G>A	MLH1	G>A	752	A424T	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	37028843	MLH1 T>C	MLH1	T>C	769	M490T	1380	Endometrial Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	37040228	MLH1 GT>AG	MLH1	GT>AG	728	V534R	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	37040279	MLH1 A>C	MLH1	A>C	751	N551T	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	37048956	MLH1 C>T	MLH1	C>T	760	A681V	9256	Colorectal Cancer	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	37050652	MLH1 A>T	MLH1	A>T	748	*757L	0050869	Villous Adenoma	""
chr3	10149921	VHL C>T	VHL	C>T	631	R200W	0060474	Chuvash Polycythemia	Ruxolitinib
chr3	38141150	MYD88 T>C	MYD88	T>C	424	L265P	1040	Chronic Lymphocytic Leukemia	IRAK-1/4 Inhibitor
chr3	38141150	MYD88 T>C	MYD88	T>C	424	L265P	1040	Chronic Lymphocytic Leukemia	IMG-2005-5
chr3	38141150	MYD88 T>C	MYD88	T>C	424	L265P	1040	Chronic Lymphocytic Leukemia	Ibrutinib
chr3	41224633	CTNNB1 A>G	CTNNB1	A>G	1285	T41A	0080366	Desmoid Tumor	""
chr3	38141150	MYD88 T>C	MYD88	T>C	424	L265P	1040	Chronic Lymphocytic Leukemia	IRAK-1/4 Inhibitor
chr3	38141150	MYD88 T>C	MYD88	T>C	424	L265P	1040	Chronic Lymphocytic Leukemia	IMG-2005-5
chr3	38141150	MYD88 T>C	MYD88	T>C	424	L265P	1040	Chronic Lymphocytic Leukemia	Ibrutinib
chr3	41224645	CTNNB1 T>C	CTNNB1	T>C	1287	S45P	0080366	Desmoid Tumor	""
chr3	38141150	MYD88 T>C	MYD88	T>C	424	L265P	1040	Chronic Lymphocytic Leukemia	IRAK-1/4 Inhibitor
chr3	38141150	MYD88 T>C	MYD88	T>C	424	L265P	1040	Chronic Lymphocytic Leukemia	IMG-2005-5
chr3	38141150	MYD88 T>C	MYD88	T>C	424	L265P	1040	Chronic Lymphocytic Leukemia	Ibrutinib
chr3	41224646	CTNNB1 C>T	CTNNB1	C>T	1286	S45F	0080366	Desmoid Tumor	Meloxicam
chr3	105720182	CBLB G>A	CBLB	G>A	643	RS2305035	3908	Lung Non-small Cell Carcinoma	""
chr3	41224646	CTNNB1 C>T	CTNNB1	C>T	1286	S45F	0080366	Desmoid Tumor	Meloxicam
chr3	138946321	FOXL2 G>C	FOXL2	G>C	198	C134W	2999	Ovarian Granulosa Cell Tumor	""
chr3	41224646	CTNNB1 C>T	CTNNB1	C>T	1286	S45F	0080366	Desmoid Tumor	Meloxicam
chr3	179199066	PIK3CA G>A	PIK3CA	G>A	1500	E81K	9256	Colorectal Cancer	Cetuximab
chr3	179199066	PIK3CA G>A	PIK3CA	G>A	1500	E81K	9256	Colorectal Cancer	Fluorouracil
chr3	179199066	PIK3CA G>A	PIK3CA	G>A	1500	E81K	9256	Colorectal Cancer	Oxaliplatin
chr3	179199088	PIK3CA G>A	PIK3CA	G>A	929	R88Q	9256	Colorectal Cancer	Cetuximab
chr3	179199088	PIK3CA G>A	PIK3CA	G>A	929	R88Q	9256	Colorectal Cancer	Fulvestrant
chr3	179199088	PIK3CA G>A	PIK3CA	G>A	929	R88Q	9256	Colorectal Cancer	Irinotecan
chr3	179199088	PIK3CA G>A	PIK3CA	G>A	929	R88Q	9256	Colorectal Cancer	Capivasertib
chr3	179199102	PIK3CA C>T	PIK3CA	C>T	1178	R93W	9256	Colorectal Cancer	Cetuximab
chr3	179199102	PIK3CA C>T	PIK3CA	C>T	1178	R93W	9256	Colorectal Cancer	Fluorouracil
chr3	179199102	PIK3CA C>T	PIK3CA	C>T	1178	R93W	9256	Colorectal Cancer	Oxaliplatin
chr3	179199158	PIK3CA G>C	PIK3CA	G>C	1234	K111N	0060079	Her2-receptor Positive Breast Cancer	Pictilisib
chr3	179199158	PIK3CA G>C	PIK3CA	G>C	1234	K111N	0060079	Her2-receptor Positive Breast Cancer	Lapatinib
chr3	179199158	PIK3CA G>C	PIK3CA	G>C	1234	K111N	0060079	Her2-receptor Positive Breast Cancer	PI3Ka/Di
chr3	179199158	PIK3CA G>C	PIK3CA	G>C	1234	K111N	0060079	Her2-receptor Positive Breast Cancer	PI-103
chr3	179199158	PIK3CA G>C	PIK3CA	G>C	1234	K111N	0060079	Her2-receptor Positive Breast Cancer	Dactolisib
chr3	179199158	PIK3CA G>C	PIK3CA	G>C	1234	K111N	0060079	Her2-receptor Positive Breast Cancer	Trastuzumab Emtansine
chr3	179199158	PIK3CA G>C	PIK3CA	G>C	1234	K111N	0060079	Her2-receptor Positive Breast Cancer	Trastuzumab
chr3	179199810	PIK3CA C>T	PIK3CA	C>T	1499	S158L	9256	Colorectal Cancer	Cetuximab
chr3	179199810	PIK3CA C>T	PIK3CA	C>T	1499	S158L	9256	Colorectal Cancer	Irinotecan
chr3	179203765	PIK3CA T>A	PIK3CA	T>A	930	N345K	9256	Colorectal Cancer	Cetuximab
chr3	179203779	PIK3CA A>G	PIK3CA	A>G	1653	D350G	1909	Melanoma	Vemurafenib
chr3	179209622	PIK3CA A>G	PIK3CA	A>G	1235	I391M	0060079	Her2-receptor Positive Breast Cancer	Trastuzumab Emtansine
chr3	179209622	PIK3CA A>G	PIK3CA	A>G	1235	I391M	0060079	Her2-receptor Positive Breast Cancer	Trastuzumab
chr3	179210192	PIK3CA T>C	PIK3CA	T>C	931	C420R	1612	Breast Cancer	Cetuximab
chr3	179210192	PIK3CA T>C	PIK3CA	T>C	931	C420R	1612	Breast Cancer	Pictilisib
chr3	179210192	PIK3CA T>C	PIK3CA	T>C	931	C420R	1612	Breast Cancer	Alpelisib
chr3	179210192	PIK3CA T>C	PIK3CA	T>C	931	C420R	1612	Breast Cancer	Trastuzumab Emtansine
chr3	179210192	PIK3CA T>C	PIK3CA	T>C	931	C420R	1612	Breast Cancer	Trastuzumab
chr3	179210192	PIK3CA T>C	PIK3CA	T>C	931	C420R	1612	Breast Cancer	Fulvestrant
chr3	179210438	PIK3CA C>T	PIK3CA	C>T	294	P471L	3965	Merkel Cell Carcinoma	Idelalisib
chr3	179218294	PIK3CA G>A	PIK3CA	G>A	103	E542K	1612	Breast Cancer	PI-103
chr3	179218294	PIK3CA G>A	PIK3CA	G>A	103	E542K	1612	Breast Cancer	Pictilisib
chr3	179218294	PIK3CA G>A	PIK3CA	G>A	103	E542K	1612	Breast Cancer	Izorlisib
chr3	179218294	PIK3CA G>A	PIK3CA	G>A	103	E542K	1612	Breast Cancer	Fulvestrant
chr3	179218294	PIK3CA G>A	PIK3CA	G>A	103	E542K	1612	Breast Cancer	Apitolisib
chr3	179218294	PIK3CA G>A	PIK3CA	G>A	103	E542K	1612	Breast Cancer	Cetuximab
chr3	179218294	PIK3CA G>A	PIK3CA	G>A	103	E542K	1612	Breast Cancer	Temsirolimus
chr3	179218294	PIK3CA G>A	PIK3CA	G>A	103	E542K	1612	Breast Cancer	Sirolimus
chr3	179218294	PIK3CA G>A	PIK3CA	G>A	103	E542K	1612	Breast Cancer	Perifosine
chr3	179218294	PIK3CA G>A	PIK3CA	G>A	103	E542K	1612	Breast Cancer	PI3Ka/Di
chr3	179218294	PIK3CA G>A	PIK3CA	G>A	103	E542K	1612	Breast Cancer	Alpelisib
chr3	179218294	PIK3CA G>A	PIK3CA	G>A	103	E542K	1612	Breast Cancer	Regorafenib
chr3	179218303	PIK3CA G>C	PIK3CA	G>C	881	E545Q	9256	Colorectal Cancer	Cetuximab
chr3	179218303	PIK3CA G>C	PIK3CA	G>C	881	E545Q	9256	Colorectal Cancer	Irinotecan
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Radiation Ionizing Radiotherapy
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	PI-103
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Vemurafenib
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Lapatinib
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Apitolisib
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Erlotinib
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Dactolisib
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Panitumumab
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Gefitinib
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Akt Inhibitor MK2206
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	PI103
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Pictilisib
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Fulvestrant
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Cisplatin
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Cetuximab
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	PI3Ka/Di
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Alpelisib
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Trastuzumab Emtansine
chr3	179218303	PIK3CA G>A	PIK3CA	G>A	104	E545K	3910	Lung Adenocarcinoma	Trastuzumab
chr3	179218304	PIK3CA A>G	PIK3CA	A>G	883	E545G	1612	Breast Cancer	Alpelisib
chr3	179218304	PIK3CA A>G	PIK3CA	A>G	883	E545G	1612	Breast Cancer	Fulvestrant
chr3	179218304	PIK3CA A>G	PIK3CA	A>G	883	E545G	1612	Breast Cancer	Vemurafenib
chr3	179218304	PIK3CA A>C	PIK3CA	A>C	882	E545A	1612	Breast Cancer	Alpelisib
chr3	179218304	PIK3CA A>C	PIK3CA	A>C	882	E545A	1612	Breast Cancer	Fulvestrant
chr3	179218305	PIK3CA G>C	PIK3CA	G>C	934	E545D	1612	Breast Cancer	Alpelisib
chr3	179218305	PIK3CA G>C	PIK3CA	G>C	934	E545D	1612	Breast Cancer	Fulvestrant
chr3	179218306	PIK3CA C>G	PIK3CA	C>G	886	Q546E	1612	Breast Cancer	Alpelisib
chr3	179218306	PIK3CA C>G	PIK3CA	C>G	886	Q546E	1612	Breast Cancer	Fulvestrant
chr3	179218306	PIK3CA C>A	PIK3CA	C>A	885	Q546K	9256	Colorectal Cancer	Cetuximab
chr3	179218306	PIK3CA C>A	PIK3CA	C>A	885	Q546K	9256	Colorectal Cancer	Irinotecan
chr3	179218307	PIK3CA A>G	PIK3CA	A>G	888	Q546R	1612	Breast Cancer	Alpelisib
chr3	179218307	PIK3CA A>G	PIK3CA	A>G	888	Q546R	1612	Breast Cancer	Fulvestrant
chr3	179230303	PIK3CA G>A	PIK3CA	G>A	3001	V955I	9256	Colorectal Cancer	Cetuximab
chr3	179234296	PIK3CA C>T	PIK3CA	C>T	938	H1047Y	1612	Breast Cancer	Alpelisib
chr3	179234296	PIK3CA C>T	PIK3CA	C>T	938	H1047Y	1612	Breast Cancer	Fulvestrant
chr3	179234297	PIK3CA A>T	PIK3CA	A>T	1151	H1047L	6587	Breast Tubular Carcinoma	Cetuximab
chr3	179234297	PIK3CA A>T	PIK3CA	A>T	1151	H1047L	6587	Breast Tubular Carcinoma	Irinotecan
chr3	179234297	PIK3CA A>T	PIK3CA	A>T	1151	H1047L	6587	Breast Tubular Carcinoma	Pictilisib
chr3	179234297	PIK3CA A>T	PIK3CA	A>T	1151	H1047L	6587	Breast Tubular Carcinoma	Alpelisib
chr3	179234297	PIK3CA A>T	PIK3CA	A>T	1151	H1047L	6587	Breast Tubular Carcinoma	PI-103
chr3	179234297	PIK3CA A>T	PIK3CA	A>T	1151	H1047L	6587	Breast Tubular Carcinoma	PI3Ka/Di
chr3	179234297	PIK3CA A>T	PIK3CA	A>T	1151	H1047L	6587	Breast Tubular Carcinoma	Fulvestrant
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Taselisib
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Vemurafenib
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Lapatinib
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Perifosine
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Irinotecan
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Panitumumab
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Dactolisib
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Akt Inhibitor MK2206
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Capivasertib
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Izorlisib
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Pictilisib
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Fulvestrant
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Cetuximab
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Everolimus
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Temsirolimus
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Alpelisib
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Trastuzumab Emtansine
chr3	179234297	PIK3CA A>G	PIK3CA	A>G	107	H1047R	3910	Lung Adenocarcinoma	Trastuzumab
chr3	179234302	PIK3CA G>C	PIK3CA	G>C	940	G1049R	9256	Colorectal Cancer	Cetuximab
chr4	1801837	FGFR3 C>T	FGFR3	C>T	2403	R248C	162	Cancer	R3Mab
chr4	1801841	FGFR3 C>G	FGFR3	C>G	628	S249C	4006	Bladder Urothelial Carcinoma	Pazopanib
chr4	1801841	FGFR3 C>G	FGFR3	C>G	628	S249C	4006	Bladder Urothelial Carcinoma	Cisplatin
chr4	1804362	FGFR3 G>T	FGFR3	G>T	2406	G370C	162	Cancer	R3Mab
chr4	1804372	FGFR3 A>G	FGFR3	A>G	2404	Y373C	11054	Urinary Bladder Cancer	R3Mab
chr4	1804392	FGFR3 G>C	FGFR3	G>C	2405	G380R			""
chr4	1804372	FGFR3 A>G	FGFR3	A>G	2404	Y373C	11054	Urinary Bladder Cancer	R3Mab
chr4	1804426	FGFR3 C>A	FGFR3	C>A	4023	A391E			""
chr4	1804372	FGFR3 A>G	FGFR3	A>G	2404	Y373C	11054	Urinary Bladder Cancer	R3Mab
chr4	1805767	FGFR3 G>A	FGFR3	G>A	2400	V555M	0070004	Myeloid Neoplasm	PD173074
chr4	1805767	FGFR3 G>A	FGFR3	G>A	2400	V555M	0070004	Myeloid Neoplasm	AZ12908010
chr4	1805767	FGFR3 G>A	FGFR3	G>A	2400	V555M	0070004	Myeloid Neoplasm	Fexagratinib
chr4	1806163	FGFR3 AA>CT	FGFR3	AA>CT	4025	K650L			""
chr4	1805767	FGFR3 G>A	FGFR3	G>A	2400	V555M	0070004	Myeloid Neoplasm	PD173074
chr4	1805767	FGFR3 G>A	FGFR3	G>A	2400	V555M	0070004	Myeloid Neoplasm	AZ12908010
chr4	1805767	FGFR3 G>A	FGFR3	G>A	2400	V555M	0070004	Myeloid Neoplasm	Fexagratinib
chr4	1806164	FGFR3 AAG>GAC	FGFR3	AAG>GAC	4024	K650D			""
chr4	1805767	FGFR3 G>A	FGFR3	G>A	2400	V555M	0070004	Myeloid Neoplasm	PD173074
chr4	1805767	FGFR3 G>A	FGFR3	G>A	2400	V555M	0070004	Myeloid Neoplasm	AZ12908010
chr4	1805767	FGFR3 G>A	FGFR3	G>A	2400	V555M	0070004	Myeloid Neoplasm	Fexagratinib
chr4	1806162	FGFR3 A>C	FGFR3	A>C	4019	K650Q			""
chr4	1805767	FGFR3 G>A	FGFR3	G>A	2400	V555M	0070004	Myeloid Neoplasm	PD173074
chr4	1805767	FGFR3 G>A	FGFR3	G>A	2400	V555M	0070004	Myeloid Neoplasm	AZ12908010
chr4	1805767	FGFR3 G>A	FGFR3	G>A	2400	V555M	0070004	Myeloid Neoplasm	Fexagratinib
chr4	1806162	FGFR3 A>G	FGFR3	A>G	1400	K650E	162	Cancer	R3Mab
chr4	1806163	FGFR3 A>C	FGFR3	A>C	4021	K650T			""
chr4	1806162	FGFR3 A>G	FGFR3	A>G	1400	K650E	162	Cancer	R3Mab
chr4	1806163	FGFR3 A>T	FGFR3	A>T	4013	K650M			""
chr4	1806162	FGFR3 A>G	FGFR3	A>G	1400	K650E	162	Cancer	R3Mab
chr4	1806164	FGFR3 G>C	FGFR3	G>C	3695	K650N			""
chr4	1806162	FGFR3 A>G	FGFR3	A>G	1400	K650E	162	Cancer	R3Mab
chr4	54274869	PDGFRA T>A	PDGFRA	T>A	941	V561D	9253	Gastrointestinal Stromal Tumor	Imatinib Mesylate
chr4	54274869	PDGFRA T>A	PDGFRA	T>A	941	V561D	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54274869	PDGFRA T>A	PDGFRA	T>A	941	V561D	9253	Gastrointestinal Stromal Tumor	Sunitinib
chr4	54274869	PDGFRA T>C	PDGFRA	T>C	247	V561A	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54274916	PDGFRA C>T	PDGFRA	C>T	862	P577S	1909	Melanoma	Crenolanib
chr4	54274916	PDGFRA C>T	PDGFRA	C>T	862	P577S	1909	Melanoma	Imatinib
chr4	54278380	PDGFRA C>T	PDGFRA	C>T	577	T674I	0080164	Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA&#44; PDGFRB&#44; And FGFR1	Imatinib
chr4	54278380	PDGFRA C>T	PDGFRA	C>T	577	T674I	0080164	Myeloid And Lymphoid Neoplasms With Eosinophilia And Abnormalities Of PDGFRA&#44; PDGFRB&#44; And FGFR1	Ponatinib
chr4	54285923	PDGFRA G>A	PDGFRA	G>A	863	R841K	1909	Melanoma	Crenolanib
chr4	54285923	PDGFRA G>A	PDGFRA	G>A	863	R841K	1909	Melanoma	Imatinib
chr4	54285925	PDGFRA G>T	PDGFRA	G>T	100	D842Y	9253	Gastrointestinal Stromal Tumor	Crenolanib
chr4	54285926	PDGFRA GA>AT	PDGFRA	GA>AT	98	D842I	9253	Gastrointestinal Stromal Tumor	Crenolanib
chr4	54285930	PDGFRA ACATC>TCATG	PDGFRA	ACATC>TCATG	102	D842_I843delinsVM	9253	Gastrointestinal Stromal Tumor	Crenolanib
chr4	54285926	PDGFRA A>T	PDGFRA	A>T	99	D842V	9253	Gastrointestinal Stromal Tumor	Imatinib Mesylate
chr4	54285926	PDGFRA A>T	PDGFRA	A>T	99	D842V	9253	Gastrointestinal Stromal Tumor	Crenolanib
chr4	54285926	PDGFRA A>T	PDGFRA	A>T	99	D842V	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54285926	PDGFRA A>T	PDGFRA	A>T	99	D842V	9253	Gastrointestinal Stromal Tumor	Sunitinib
chr4	54285934	PDGFRA C>T	PDGFRA	C>T	864	H845Y	1909	Melanoma	Crenolanib
chr4	54285934	PDGFRA C>T	PDGFRA	C>T	864	H845Y	1909	Melanoma	Imatinib
chr4	54285959	PDGFRA G>A	PDGFRA	G>A	865	G853D	1909	Melanoma	Crenolanib
chr4	54285959	PDGFRA G>A	PDGFRA	G>A	865	G853D	1909	Melanoma	Imatinib
chr4	54727298	KIT A>C	KIT	A>C	201	M541L	1036	Chronic Leukemia	Imatinib
chr4	54727442	KIT G>TCCT	KIT	G>TCCT	1549	K558delinsNP	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54727442	KIT G>TCCT	KIT	G>TCCT	1549	K558delinsNP	9253	Gastrointestinal Stromal Tumor	Sunitinib
chr4	54727442	KIT G>TCCT	KIT	G>TCCT	1549	K558delinsNP	9253	Gastrointestinal Stromal Tumor	Ponatinib
chr4	54727442	KIT G>TCCT	KIT	G>TCCT	1549	K558delinsNP	9253	Gastrointestinal Stromal Tumor	Regorafenib
chr4	54727444	KIT T>A	KIT	T>A	968	V559D	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54727444	KIT T>A	KIT	T>A	968	V559D	9253	Gastrointestinal Stromal Tumor	PD-180970
chr4	54727444	KIT T>A	KIT	T>A	968	V559D	9253	Gastrointestinal Stromal Tumor	Dasatinib
chr4	54727444	KIT T>A	KIT	T>A	968	V559D	9253	Gastrointestinal Stromal Tumor	Sunitinib
chr4	54727444	KIT T>A	KIT	T>A	968	V559D	9253	Gastrointestinal Stromal Tumor	Ponatinib
chr4	54727444	KIT T>A	KIT	T>A	968	V559D	9253	Gastrointestinal Stromal Tumor	Tandutinib
chr4	54727444	KIT T>A	KIT	T>A	968	V559D	9253	Gastrointestinal Stromal Tumor	Regorafenib
chr4	54727447	KIT T>G	KIT	T>G	972	V560G	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54727447	KIT T>G	KIT	T>G	972	V560G	9253	Gastrointestinal Stromal Tumor	Ponatinib
chr4	54727447	KIT T>G	KIT	T>G	972	V560G	9253	Gastrointestinal Stromal Tumor	Regorafenib
chr4	54727447	KIT T>A	KIT	T>A	971	V560D	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54727447	KIT T>A	KIT	T>A	971	V560D	9253	Gastrointestinal Stromal Tumor	Sunitinib
chr4	54727447	KIT T>A	KIT	T>A	971	V560D	9253	Gastrointestinal Stromal Tumor	Ponatinib
chr4	54727447	KIT T>A	KIT	T>A	971	V560D	9253	Gastrointestinal Stromal Tumor	Imatinib Mesylate
chr4	54727447	KIT T>A	KIT	T>A	971	V560D	9253	Gastrointestinal Stromal Tumor	Regorafenib
chr4	54727495	KIT T>C	KIT	T>C	72	L576P	3908	Lung Non-small Cell Carcinoma	Imatinib
chr4	54727495	KIT T>C	KIT	T>C	72	L576P	3908	Lung Non-small Cell Carcinoma	Dasatinib
chr4	54727495	KIT T>C	KIT	T>C	72	L576P	3908	Lung Non-small Cell Carcinoma	Sunitinib
chr4	54727495	KIT T>C	KIT	T>C	72	L576P	3908	Lung Non-small Cell Carcinoma	Sorafenib
chr4	54727495	KIT T>C	KIT	T>C	72	L576P	3908	Lung Non-small Cell Carcinoma	Nilotinib
chr4	54728014	KIT G>A	KIT	G>A	1659	S628N	1909	Melanoma	Imatinib
chr4	54728014	KIT G>A	KIT	G>A	1659	S628N	1909	Melanoma	Dasatinib
chr4	54728055	KIT A>G	KIT	A>G	978	K642E	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54728055	KIT A>G	KIT	A>G	978	K642E	9253	Gastrointestinal Stromal Tumor	Dasatinib
chr4	54728055	KIT A>G	KIT	A>G	978	K642E	9253	Gastrointestinal Stromal Tumor	Sunitinib
chr4	54728055	KIT A>G	KIT	A>G	978	K642E	9253	Gastrointestinal Stromal Tumor	Ponatinib
chr4	54728092	KIT T>C	KIT	T>C	73	V654A	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54728092	KIT T>C	KIT	T>C	73	V654A	9253	Gastrointestinal Stromal Tumor	Sunitinib
chr4	54729353	KIT C>T	KIT	C>T	1267	T670I	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54729353	KIT C>T	KIT	C>T	1267	T670I	9253	Gastrointestinal Stromal Tumor	Sunitinib
chr4	54729353	KIT C>T	KIT	C>T	1267	T670I	9253	Gastrointestinal Stromal Tumor	Regorafenib
chr4	54729353	KIT C>T	KIT	C>T	1267	T670I	9253	Gastrointestinal Stromal Tumor	Ponatinib
chr4	54733133	KIT T>G	KIT	T>G	1264	C809G	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54733154	KIT G>C	KIT	G>C	983	D816H	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54733155	KIT A>T	KIT	A>T	65	D816V	9119	Acute Myeloid Leukemia	Imatinib Mesylate
chr4	54733155	KIT A>T	KIT	A>T	65	D816V	9119	Acute Myeloid Leukemia	Midostaurin
chr4	54733155	KIT A>T	KIT	A>T	65	D816V	9119	Acute Myeloid Leukemia	Dasatinib
chr4	54733155	KIT A>T	KIT	A>T	65	D816V	9119	Acute Myeloid Leukemia	Imatinib
chr4	54733156	KIT C>G	KIT	C>G	1559	D816E	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54733156	KIT C>G	KIT	C>G	1559	D816E	9253	Gastrointestinal Stromal Tumor	Sunitinib
chr4	54733156	KIT C>G	KIT	C>G	1559	D816E	9253	Gastrointestinal Stromal Tumor	Ponatinib
chr4	54733166	KIT G>T	KIT	G>T	986	D820Y	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54733166	KIT G>T	KIT	G>T	986	D820Y	9253	Gastrointestinal Stromal Tumor	Sunitinib
chr4	54733166	KIT G>T	KIT	G>T	986	D820Y	9253	Gastrointestinal Stromal Tumor	Regorafenib
chr4	54733167	KIT A>G	KIT	A>G	1266	D820G	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54733167	KIT A>C	KIT	A>C	1265	D820A	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54733172	KIT A>C	KIT	A>C	987	N822H	162	Cancer	Imatinib
chr4	54733174	KIT T>A	KIT	T>A	1263	N822K	9119	Acute Myeloid Leukemia	Imatinib
chr4	54733174	KIT T>A	KIT	T>A	1263	N822K	9119	Acute Myeloid Leukemia	Ponatinib
chr4	54733174	KIT T>A	KIT	T>A	1263	N822K	9119	Acute Myeloid Leukemia	Sunitinib
chr4	54733174	KIT T>A	KIT	T>A	1263	N822K	9119	Acute Myeloid Leukemia	Sorafenib
chr4	54733174	KIT T>A	KIT	T>A	1263	N822K	9119	Acute Myeloid Leukemia	Regorafenib
chr4	54733175	KIT T>G	KIT	T>G	989	Y823D	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54736498	KIT G>C	KIT	G>C	990	A829P	9253	Gastrointestinal Stromal Tumor	Imatinib
chr4	54736498	KIT G>C	KIT	G>C	990	A829P	9253	Gastrointestinal Stromal Tumor	Sunitinib
chr4	54736498	KIT G>C	KIT	G>C	990	A829P	9253	Gastrointestinal Stromal Tumor	Ponatinib
chr4	54736599	KIT G>C	KIT	G>C	482	RS3733542	9119	Acute Myeloid Leukemia	Selumetinib
chr4	54738774	KIT G>A	KIT	G>A	256	rs17084733	6367	Acral Lentiginous Melanoma	""
chr4	54736599	KIT G>C	KIT	G>C	482	RS3733542	9119	Acute Myeloid Leukemia	Selumetinib
chr4	55089802	KDR C>T	KDR	C>T	467	A1065T	0001816	Angiosarcoma	Sorafenib
chr4	55089802	KDR C>T	KDR	C>T	467	A1065T	0001816	Angiosarcoma	Sunitinib
chr4	55094892	KDR G>A	KDR	G>A	502	R961W	0050861	Colorectal Adenocarcinoma	Regorafenib
chr4	55102013	KDR T>A	KDR	T>A	468	D717V	0001816	Angiosarcoma	Sorafenib
chr4	55102013	KDR T>A	KDR	T>A	468	D717V	0001816	Angiosarcoma	Sunitinib
chr4	88131171	ABCG2 G>T	ABCG2	G>T	260	Q141K	2394	Ovarian Cancer	""
chr4	55102013	KDR T>A	KDR	T>A	468	D717V	0001816	Angiosarcoma	Sorafenib
chr4	55102013	KDR T>A	KDR	T>A	468	D717V	0001816	Angiosarcoma	Sunitinib
chr5	1286401	TERT C>A	TERT	C>A	421	RS2736100	0060108	Brain Glioma	""
chr4	55102013	KDR T>A	KDR	T>A	468	D717V	0001816	Angiosarcoma	Sorafenib
chr4	55102013	KDR T>A	KDR	T>A	468	D717V	0001816	Angiosarcoma	Sunitinib
chr5	1295113	TERT G>A	TERT	G>A	248	C228T	1781	Thyroid Cancer	""
chr4	55102013	KDR T>A	KDR	T>A	468	D717V	0001816	Angiosarcoma	Sorafenib
chr4	55102013	KDR T>A	KDR	T>A	468	D717V	0001816	Angiosarcoma	Sunitinib
chr5	177515766	DDX41 G>A	DDX41	G>A	814	R164W	2531	Hematologic Cancer	""
chr4	55102013	KDR T>A	KDR	T>A	468	D717V	0001816	Angiosarcoma	Sorafenib
chr4	55102013	KDR T>A	KDR	T>A	468	D717V	0001816	Angiosarcoma	Sunitinib
chr6	117308899	ROS1 A>G	ROS1	A>G	517	L2155S	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr6	117308899	ROS1 A>G	ROS1	A>G	517	L2155S	3908	Lung Non-small Cell Carcinoma	ALK Inhibitor TAE684
chr6	117308899	ROS1 A>G	ROS1	A>G	517	L2155S	3908	Lung Non-small Cell Carcinoma	Foretinib
chr6	117310213	ROS1 C>G	ROS1	C>G	518	G2101A	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr6	117310213	ROS1 C>G	ROS1	C>G	518	G2101A	3908	Lung Non-small Cell Carcinoma	Foretinib
chr6	117317184	ROS1 C>T	ROS1	C>T	1271	G2032R	3910	Lung Adenocarcinoma	Crizotinib
chr6	117317184	ROS1 C>T	ROS1	C>T	1271	G2032R	3910	Lung Adenocarcinoma	Brigatinib
chr6	117317184	ROS1 C>T	ROS1	C>T	1271	G2032R	3910	Lung Adenocarcinoma	Cabozantinib
chr6	117317184	ROS1 C>T	ROS1	C>T	1271	G2032R	3910	Lung Adenocarcinoma	Ceritinib
chr6	117317184	ROS1 C>T	ROS1	C>T	1271	G2032R	3910	Lung Adenocarcinoma	AZD3463
chr6	117317184	ROS1 C>T	ROS1	C>T	1271	G2032R	3910	Lung Adenocarcinoma	Lorlatinib
chr6	117317184	ROS1 C>T	ROS1	C>T	1271	G2032R	3910	Lung Adenocarcinoma	Foretinib
chr6	117317184	ROS1 C>T	ROS1	C>T	1271	G2032R	3910	Lung Adenocarcinoma	DS-6501b
chr6	117317202	ROS1 G>T	ROS1	G>T	516	L2026M	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr6	117317202	ROS1 G>T	ROS1	G>T	516	L2026M	3908	Lung Non-small Cell Carcinoma	Lorlatinib
chr6	117317202	ROS1 G>T	ROS1	G>T	516	L2026M	3908	Lung Non-small Cell Carcinoma	Foretinib
chr6	152094402	ESR1 T>C	ESR1	T>C	692	S463P	0060075	Estrogen-receptor Positive Breast Cancer	Aromatase Inhibitor
chr6	152098786	ESR1 TC>AG	ESR1	TC>AG	46	L536Q	1612	Breast Cancer	Hormone Therapy
chr6	152098786	ESR1 TC>AG	ESR1	TC>AG	46	L536Q	1612	Breast Cancer	Tamoxifen
chr6	152098786	ESR1 TC>AG	ESR1	TC>AG	46	L536Q	1612	Breast Cancer	Fulvestrant
chr6	152098787	ESR1 T>A	ESR1	T>A	49	Y537N	1612	Breast Cancer	Hormone Therapy
chr6	152098787	ESR1 T>A	ESR1	T>A	49	Y537N	1612	Breast Cancer	Tamoxifen
chr6	152098787	ESR1 T>A	ESR1	T>A	49	Y537N	1612	Breast Cancer	Fulvestrant
chr6	152098788	ESR1 A>C	ESR1	A>C	50	Y537S	1612	Breast Cancer	Hormone Therapy
chr6	152098788	ESR1 A>C	ESR1	A>C	50	Y537S	1612	Breast Cancer	Tamoxifen
chr6	152098788	ESR1 A>C	ESR1	A>C	50	Y537S	1612	Breast Cancer	Fulvestrant
chr6	152098788	ESR1 A>G	ESR1	A>G	48	Y537C	1612	Breast Cancer	Hormone Therapy
chr6	152098788	ESR1 A>G	ESR1	A>G	48	Y537C	1612	Breast Cancer	Tamoxifen
chr6	152098788	ESR1 A>G	ESR1	A>G	48	Y537C	1612	Breast Cancer	Fulvestrant
chr6	152098791	ESR1 A>G	ESR1	A>G	47	D538G	1612	Breast Cancer	Hormone Therapy
chr6	152098791	ESR1 A>G	ESR1	A>G	47	D538G	1612	Breast Cancer	Letrozole
chr6	152098791	ESR1 A>G	ESR1	A>G	47	D538G	1612	Breast Cancer	Tamoxifen
chr6	152098791	ESR1 A>G	ESR1	A>G	47	D538G	1612	Breast Cancer	Fulvestrant
chr6	152098791	ESR1 A>G	ESR1	A>G	47	D538G	1612	Breast Cancer	Palbociclib
chr7	5992018	PMS2 G>A	PMS2	G>A	768	R315*	1380	Endometrial Cancer	""
chr6	152098791	ESR1 A>G	ESR1	A>G	47	D538G	1612	Breast Cancer	Hormone Therapy
chr6	152098791	ESR1 A>G	ESR1	A>G	47	D538G	1612	Breast Cancer	Letrozole
chr6	152098791	ESR1 A>G	ESR1	A>G	47	D538G	1612	Breast Cancer	Tamoxifen
chr6	152098791	ESR1 A>G	ESR1	A>G	47	D538G	1612	Breast Cancer	Fulvestrant
chr6	152098791	ESR1 A>G	ESR1	A>G	47	D538G	1612	Breast Cancer	Palbociclib
chr7	6387261	RAC1 C>T	RAC1	C>T	367	P29S	1909	Melanoma	Dabrafenib
chr7	6387261	RAC1 C>T	RAC1	C>T	367	P29S	1909	Melanoma	Vemurafenib
chr7	55143387	EGFR G>A	EGFR	G>A	994	R108K	3070	High Grade Glioma	Erlotinib
chr7	55152581	EGFR C>T	EGFR	C>T	3344	R222C			""
chr7	55143387	EGFR G>A	EGFR	G>A	994	R108K	3070	High Grade Glioma	Erlotinib
chr7	55154050	EGFR A>C	EGFR	A>C	995	T263P	3070	High Grade Glioma	Erlotinib
chr7	55154129	EGFR C>T	EGFR	C>T	996	A289V	3070	High Grade Glioma	Erlotinib
chr7	55160161	EGFR G>T	EGFR	G>T	2613	V441F	9256	Colorectal Cancer	Cetuximab
chr7	55160161	EGFR G>T	EGFR	G>T	2613	V441F	9256	Colorectal Cancer	Panitumumab
chr7	55160191	EGFR C>T	EGFR	C>T	454	R451C	9256	Colorectal Cancer	Panitumumab
chr7	55160191	EGFR C>T	EGFR	C>T	454	R451C	9256	Colorectal Cancer	Cetuximab
chr7	55160191	EGFR C>T	EGFR	C>T	454	R451C	9256	Colorectal Cancer	Futuximab/Modotuximab Mixture
chr7	55160233	EGFR G>A	EGFR	G>A	443	G465R	9256	Colorectal Cancer	Panitumumab
chr7	55160233	EGFR G>A	EGFR	G>A	443	G465R	9256	Colorectal Cancer	Cetuximab
chr7	55160233	EGFR G>A	EGFR	G>A	443	G465R	9256	Colorectal Cancer	Futuximab/Modotuximab Mixture
chr7	55160240	EGFR A>C	EGFR	A>C	455	K467T	9256	Colorectal Cancer	Panitumumab
chr7	55160240	EGFR A>C	EGFR	A>C	455	K467T	9256	Colorectal Cancer	Cetuximab
chr7	55160240	EGFR A>C	EGFR	A>C	455	K467T	9256	Colorectal Cancer	Futuximab/Modotuximab Mixture
chr7	55160316	EGFR C>A	EGFR	C>A	453	S492R	9256	Colorectal Cancer	Cetuximab
chr7	55160316	EGFR C>A	EGFR	C>A	453	S492R	9256	Colorectal Cancer	Panitumumab
chr7	55160316	EGFR C>A	EGFR	C>A	453	S492R	9256	Colorectal Cancer	Futuximab/Modotuximab Mixture
chr7	55165350	EGFR G>T	EGFR	G>T	997	G598V	162	Cancer	Erlotinib
chr7	55173973	EGFR G>A	EGFR	G>A	2333	R705K	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55173973	EGFR G>A	EGFR	G>A	2333	R705K	3908	Lung Non-small Cell Carcinoma	Erlotinib
chr7	55174014	EGFR G>A	EGFR	G>A	134	G719S	9256	Colorectal Cancer	Cetuximab
chr7	55174014	EGFR G>A	EGFR	G>A	134	G719S	9256	Colorectal Cancer	Gefitinib
chr7	55174014	EGFR G>A	EGFR	G>A	134	G719S	9256	Colorectal Cancer	Erlotinib
chr7	55174015	EGFR G>A	EGFR	G>A	1420	G719D	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55174015	EGFR G>A	EGFR	G>A	1420	G719D	3908	Lung Non-small Cell Carcinoma	Erlotinib
chr7	55174015	EGFR G>C	EGFR	G>C	999	G719A	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55174015	EGFR G>C	EGFR	G>C	999	G719A	3908	Lung Non-small Cell Carcinoma	Afatinib
chr7	55174015	EGFR G>C	EGFR	G>C	999	G719A	3908	Lung Non-small Cell Carcinoma	Erlotinib
chr7	55174029	EGFR G>A	EGFR	G>A	317	G724S	9256	Colorectal Cancer	Cetuximab
chr7	55174729	EGFR G>T	EGFR	G>T	1571	W731L	162	Cancer	Erlotinib
chr7	55174737	EGFR G>C	EGFR	G>C	1572	E734Q	162	Cancer	Erlotinib
chr7	55174762	EGFR T>C	EGFR	T>C	1001	V742A	3908	Lung Non-small Cell Carcinoma	Erlotinib
chr7	55174774	EGFR A>G	EGFR	A>G	724	E746G	3910	Lung Adenocarcinoma	Erlotinib
chr7	55174777	EGFR TT>CC	EGFR	TT>CC	1891	L747P	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55174777	EGFR TT>CC	EGFR	TT>CC	1891	L747P	3908	Lung Non-small Cell Carcinoma	Erlotinib
chr7	55174794	EGFR C>T	EGFR	C>T	460	P753S	3151	Skin Squamous Cell Carcinoma	Cetuximab
chr7	55174794	EGFR C>T	EGFR	C>T	460	P753S	3151	Skin Squamous Cell Carcinoma	Sirolimus
chr7	55174807	EGFR A>G	EGFR	A>G	723	K757R	3910	Lung Adenocarcinoma	Erlotinib
chr7	55174818	EGFR G>T	EGFR	G>T	712	D761Y	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55174818	EGFR G>T	EGFR	G>T	712	D761Y	3908	Lung Non-small Cell Carcinoma	Erlotinib
chr7	55181312	EGFR G>T	EGFR	G>T	562	S768I	3910	Lung Adenocarcinoma	Gefitinib
chr7	55181312	EGFR G>T	EGFR	G>T	562	S768I	3910	Lung Adenocarcinoma	Afatinib
chr7	55181312	EGFR G>T	EGFR	G>T	562	S768I	3910	Lung Adenocarcinoma	Erlotinib
chr7	55181329	EGFR G>A	EGFR	G>A	1894	V774M	3908	Lung Non-small Cell Carcinoma	Erlotinib
chr7	55181330	EGFR T>C	EGFR	T>C	1892	V774A	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55181335	EGFR C>T	EGFR	C>T	1181	R776C	3908	Lung Non-small Cell Carcinoma	Erlotinib
chr7	55181362	EGFR A>G	EGFR	A>G	1573	T785A	162	Cancer	Erlotinib
chr7	55181378	EGFR C>T	EGFR	C>T	34	T790M	3910	Lung Adenocarcinoma	Afatinib
chr7	55181378	EGFR C>T	EGFR	C>T	34	T790M	3910	Lung Adenocarcinoma	Neratinib
chr7	55181378	EGFR C>T	EGFR	C>T	34	T790M	3910	Lung Adenocarcinoma	Staurosporine
chr7	55181378	EGFR C>T	EGFR	C>T	34	T790M	3910	Lung Adenocarcinoma	Osimertinib
chr7	55181378	EGFR C>T	EGFR	C>T	34	T790M	3910	Lung Adenocarcinoma	Lapatinib
chr7	55181378	EGFR C>T	EGFR	C>T	34	T790M	3910	Lung Adenocarcinoma	Canertinib
chr7	55181378	EGFR C>T	EGFR	C>T	34	T790M	3910	Lung Adenocarcinoma	Rociletinib
chr7	55181378	EGFR C>T	EGFR	C>T	34	T790M	3910	Lung Adenocarcinoma	Erlotinib
chr7	55181378	EGFR C>T	EGFR	C>T	34	T790M	3910	Lung Adenocarcinoma	Multikinase Inhibitor AEE788
chr7	55181378	EGFR C>T	EGFR	C>T	34	T790M	3910	Lung Adenocarcinoma	Dacomitinib
chr7	55181378	EGFR C>T	EGFR	C>T	34	T790M	3910	Lung Adenocarcinoma	Gefitinib
chr7	55181378	EGFR C>T	EGFR	C>T	34	T790M	3910	Lung Adenocarcinoma	Pemetrexed
chr7	55181398	EGFR T>A	EGFR	T>A	415	C797S	3910	Lung Adenocarcinoma	Osimertinib
chr7	55181399	EGFR G>A	EGFR	G>A	1574	C797Y	162	Cancer	Erlotinib
chr7	55181410	EGFR T>C	EGFR	T>C	1575	Y801H	162	Cancer	Erlotinib
chr7	55181425	EGFR A>G	EGFR	A>G	1895	K806E	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55191725	EGFR A>T	EGFR	A>T	1896	N826Y	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55191726	EGFR A>G	EGFR	A>G	1188	N826S	3908	Lung Non-small Cell Carcinoma	Erlotinib
chr7	55191741	EGFR G>A	EGFR	G>A	1017	R831H	162	Cancer	Erlotinib
chr7	55191761	EGFR C>G	EGFR	C>G	1018	L838V	162	Cancer	Gefitinib
chr7	55191761	EGFR C>G	EGFR	C>G	1018	L838V	162	Cancer	Erlotinib
chr7	55191762	EGFR T>C	EGFR	T>C	1457	L838P	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55191774	EGFR A>G	EGFR	A>G	1899	N842S	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55191789	EGFR C>T	EGFR	C>T	1463	T847I	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55191800	EGFR G>A	EGFR	G>A	1466	V851I	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Afatinib
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Neratinib
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Lapatinib
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Osimertinib
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Carboplatin
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Canertinib
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Crizotinib
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Cetuximab
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Chemotherapy
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Erlotinib
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Amivantamab
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Multikinase Inhibitor AEE788
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Dacomitinib
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Gefitinib
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Lazertinib
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Pemetrexed
chr7	55191822	EGFR T>G	EGFR	T>G	33	L858R	3910	Lung Adenocarcinoma	Ramucirumab
chr7	55191831	EGFR T>G	EGFR	T>G	1477	L861R	3908	Lung Non-small Cell Carcinoma	Gefitinib
chr7	55191831	EGFR T>A	EGFR	T>A	1020	L861Q	3070	High Grade Glioma	Gefitinib
chr7	55191831	EGFR T>A	EGFR	T>A	1020	L861Q	3070	High Grade Glioma	Afatinib
chr7	55191831	EGFR T>A	EGFR	T>A	1020	L861Q	3070	High Grade Glioma	Erlotinib
chr7	55191839	EGFR G>A	EGFR	G>A	1187	A864T	3908	Lung Non-small Cell Carcinoma	Erlotinib
chr7	55191852	EGFR A>G	EGFR	A>G	1482	E868G	162	Cancer	Erlotinib
chr7	87509329	ABCB1 A>G	ABCB1	A>G	263	I1145I	1612	Breast Cancer	Carboplatin
chr7	87509329	ABCB1 A>G	ABCB1	A>G	263	I1145I	1612	Breast Cancer	Cisplatin
chr7	87531302	ABCB1 A>C	ABCB1	A>C	451	S893A/T	1612	Breast Cancer	""
chr7	87509329	ABCB1 A>G	ABCB1	A>G	263	I1145I	1612	Breast Cancer	Carboplatin
chr7	87509329	ABCB1 A>G	ABCB1	A>G	263	I1145I	1612	Breast Cancer	Cisplatin
chr7	87531302	ABCB1 A>T	ABCB1	A>T	262	S893T	2394	Ovarian Cancer	Paclitaxel
chr7	116771971	MET C>G	MET	C>G	2774	R1004G	11934	Head And Neck Cancer	Crizotinib
chr7	116783353	MET G>A	MET	G>A	649	D1228N	3908	Lung Non-small Cell Carcinoma	Crizotinib
chr7	116783354	MET A>T	MET	A>T	798	D1228V	3908	Lung Non-small Cell Carcinoma	Savolitinib
chr7	116783354	MET A>T	MET	A>T	798	D1228V	3908	Lung Non-small Cell Carcinoma	Cabozantinib
chr7	129206557	SMO C>T	SMO	C>T	1570	L412F	2513	Basal Cell Carcinoma	Vismodegib
chr7	129209348	SMO G>C	SMO	G>C	299	D473H	2513	Basal Cell Carcinoma	Vismodegib
chr7	129209348	SMO G>C	SMO	G>C	299	D473H	2513	Basal Cell Carcinoma	Patidegib
chr7	140734707	BRAF G>T	BRAF	G>T	2224	P731T	162	Cancer	Vemurafenib
chr7	140734715	BRAF G>A	BRAF	G>A	1198	A728V			""
chr7	140734707	BRAF G>T	BRAF	G>T	2224	P731T	162	Cancer	Vemurafenib
chr7	140753318	BRAF C>T	BRAF	C>T	2223	G606E	162	Cancer	Vemurafenib
chr7	140753334	BRAF T>C	BRAF	T>C	584	K601E	9256	Colorectal Cancer	Vemurafenib
chr7	140753334	BRAF T>C	BRAF	T>C	584	K601E	9256	Colorectal Cancer	Cobimetinib
chr7	140753334	BRAF T>C	BRAF	T>C	584	K601E	9256	Colorectal Cancer	Trametinib
chr7	140753336	BRAF CA>AT	BRAF	CA>AT	11	V600D	1909	Melanoma	Dabrafenib
chr7	140753336	BRAF CA>AT	BRAF	CA>AT	11	V600D	1909	Melanoma	Vemurafenib
chr7	140753336	BRAF CA>AT	BRAF	CA>AT	11	V600D	1909	Melanoma	Mitogen-Activated Protein Kinase Kinase Inhibitor
chr7	140753336	BRAF CA>AT	BRAF	CA>AT	11	V600D	1909	Melanoma	BRAF Inhibitor
chr7	140753337	BRAF AC>TT	BRAF	AC>TT	563	V600K	1909	Melanoma	Dabrafenib
chr7	140753337	BRAF AC>TT	BRAF	AC>TT	563	V600K	1909	Melanoma	Vemurafenib
chr7	140753337	BRAF AC>TT	BRAF	AC>TT	563	V600K	1909	Melanoma	Cobimetinib
chr7	140753337	BRAF AC>TT	BRAF	AC>TT	563	V600K	1909	Melanoma	Trametinib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Mirdametinib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Bevacizumab
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	JQEZ5
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Vemurafenib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	PLX4720
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Encorafenib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Nutlin-3
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Erlotinib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Irinotecan
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Panitumumab
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Dactolisib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Gefitinib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	FOLFOX-4 Regimen
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Dabrafenib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Pictilisib Bismesylate
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Pertuzumab
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Binimetinib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Pictilisib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Sorafenib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Tovorafenib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	MEK Inhibitor RO4987655
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Oxaliplatin
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Trametinib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Cetuximab
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Capecitabine
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	GDC-0879
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Selumetinib
chr7	140753336	BRAF A>T	BRAF	A>T	12	V600E	9256	Colorectal Cancer	Cobimetinib
chr7	140753337	BRAF C>T	BRAF	C>T	1405	V600M	1909	Melanoma	Dabrafenib
chr7	140753342	BRAF G>A	BRAF	G>A	2826	A598V	1909	Melanoma	Mitogen-Activated Protein Kinase Kinase Inhibitor
chr7	140753342	BRAF G>A	BRAF	G>A	2826	A598V	1909	Melanoma	BRAF Inhibitor
chr7	140753345	BRAF A>T	BRAF	A>T	583	L597Q	162	Cancer	Vemurafenib
chr7	140753345	BRAF A>T	BRAF	A>T	583	L597Q	162	Cancer	Trametinib
chr7	140753346	BRAF AG>GA	BRAF	AG>GA	582	L597S	8923	Skin Melanoma	MEK Inhibitor REC-4881
chr7	140753346	BRAF AG>GA	BRAF	AG>GA	582	L597S	8923	Skin Melanoma	Vemurafenib
chr7	140753346	BRAF AG>GA	BRAF	AG>GA	582	L597S	8923	Skin Melanoma	Trametinib
chr7	140753345	BRAF A>C	BRAF	A>C	288	L597R	1909	Melanoma	Trametinib
chr7	140753345	BRAF A>C	BRAF	A>C	288	L597R	1909	Melanoma	Vemurafenib
chr7	140753346	BRAF G>C	BRAF	G>C	585	L597V	8923	Skin Melanoma	Trametinib
chr7	140753349	BRAF C>G	BRAF	C>G	1627	G596R	9256	Colorectal Cancer	Vemurafenib
chr7	140753349	BRAF C>A	BRAF	C>A	694	G596C	3908	Lung Non-small Cell Carcinoma	Dabrafenib
chr7	140753349	BRAF C>A	BRAF	C>A	694	G596C	3908	Lung Non-small Cell Carcinoma	Trametinib
chr7	140753354	BRAF T>C	BRAF	T>C	611	D594G	9256	Colorectal Cancer	Cetuximab
chr7	140753354	BRAF T>C	BRAF	T>C	611	D594G	9256	Colorectal Cancer	Vemurafenib
chr7	140753354	BRAF T>C	BRAF	T>C	611	D594G	9256	Colorectal Cancer	Irinotecan
chr7	140753354	BRAF T>C	BRAF	T>C	611	D594G	9256	Colorectal Cancer	U0126
chr7	140753354	BRAF T>C	BRAF	T>C	611	D594G	9256	Colorectal Cancer	Panitumumab
chr7	140753354	BRAF T>C	BRAF	T>C	611	D594G	9256	Colorectal Cancer	Sorafenib
chr7	140753354	BRAF T>C	BRAF	T>C	611	D594G	9256	Colorectal Cancer	Trametinib
chr7	140753354	BRAF T>A	BRAF	T>A	580	D594V	8923	Skin Melanoma	Sorafenib
chr7	140753354	BRAF T>A	BRAF	T>A	580	D594V	8923	Skin Melanoma	Trametinib
chr7	140753354	BRAF T>G	BRAF	T>G	579	D594A	8923	Skin Melanoma	Sorafenib
chr7	140753354	BRAF T>G	BRAF	T>G	579	D594A	8923	Skin Melanoma	Mitogen-Activated Protein Kinase Kinase Inhibitor
chr7	140753393	BRAF T>C	BRAF	T>C	1186	N581S	162	Cancer	Vemurafenib
chr7	140777994	BRAF A>T	BRAF	A>T	658	L505H	1909	Melanoma	Vemurafenib
chr7	140778060	BRAF TT>CA	BRAF	TT>CA	581	K483M	8923	Skin Melanoma	Sorafenib
chr7	140778060	BRAF TT>CA	BRAF	TT>CA	581	K483M	8923	Skin Melanoma	Mitogen-Activated Protein Kinase Kinase Inhibitor
chr7	140781602	BRAF C>T	BRAF	C>T	993	G469E	8923	Skin Melanoma	Sorafenib
chr7	140781602	BRAF C>T	BRAF	C>T	993	G469E	8923	Skin Melanoma	U0126
chr7	140781602	BRAF C>G	BRAF	C>G	992	G469A	162	Cancer	Vemurafenib
chr7	140781611	BRAF C>A	BRAF	C>A	2222	G466V	9256	Colorectal Cancer	Panitumumab
chr7	140781611	BRAF C>A	BRAF	C>A	2222	G466V	9256	Colorectal Cancer	Irinotecan
chr7	140781611	BRAF C>A	BRAF	C>A	2222	G466V	9256	Colorectal Cancer	Vemurafenib
chr7	140781617	BRAF C>A	BRAF	C>A	1106	G464V	162	Cancer	Vemurafenib
chr7	148809345	EZH2 G>A	EZH2	G>A	4414	A692V	0050873	Follicular Lymphoma	Tazemetostat
chr7	148809375	EZH2 G>C	EZH2	G>C	4415	A682G	0050873	Follicular Lymphoma	Tazemetostat
chr7	148811635	EZH2 T>C	EZH2	T>C	3607	Y646C	0050873	Follicular Lymphoma	Tazemetostat
chr7	148811635	EZH2 T>A	EZH2	T>A	2989	Y646F	707	B-cell Lymphoma	JQEZ5
chr7	148811635	EZH2 T>A	EZH2	T>A	2989	Y646F	707	B-cell Lymphoma	Tazemetostat
chr7	148811635	EZH2 T>G	EZH2	T>G	2666	Y646S	0050873	Follicular Lymphoma	Tazemetostat
chr7	148811636	EZH2 A>T	EZH2	A>T	4090	Y646N	0050873	Follicular Lymphoma	Tazemetostat
chr7	148811636	EZH2 A>G	EZH2	A>G	3364	Y646H	0050873	Follicular Lymphoma	Tazemetostat
chr7	148827660	EZH2 C>C	EZH2	C>C	257	Intron	9256	Colorectal Cancer	""
chr7	148811636	EZH2 A>G	EZH2	A>G	3364	Y646H	0050873	Follicular Lymphoma	Tazemetostat
chr8	38417331	FGFR1 G>T	FGFR1	G>T	515	N546K	3368	Ewing Sarcoma Of Bone	Ponatinib
chr8	38417331	FGFR1 G>T	FGFR1	G>T	515	N546K	3368	Ewing Sarcoma Of Bone	Pemigatinib
chr8	68027295	PREX2 G>T	PREX2	G>T	2364	R172I	1909	Melanoma	Vemurafenib
chr9	5070054	JAK2 T>G	JAK2	T>G	1681	Splice	1909	Melanoma	Pembrolizumab
chr9	5073770	JAK2 G>T	JAK2	G>T	64	V617F	8552	Chronic Myeloid Leukemia	Fedratinib
chr9	5073770	JAK2 G>T	JAK2	G>T	64	V617F	8552	Chronic Myeloid Leukemia	Peginterferon Alfa-2b
chr9	8521481	PTPRD C>T	PTPRD	C>T	792	V253I	3368	Ewing Sarcoma Of Bone	Cixutumumab
chr9	8521481	PTPRD C>T	PTPRD	C>T	792	V253I	3368	Ewing Sarcoma Of Bone	Teprotumumab
chr9	21975018	CDKN2A C>T	CDKN2A	C>T	641	RS3814960	3748	Esophagus Squamous Cell Carcinoma	""
chr9	8521481	PTPRD C>T	PTPRD	C>T	792	V253I	3368	Ewing Sarcoma Of Bone	Cixutumumab
chr9	8521481	PTPRD C>T	PTPRD	C>T	792	V253I	3368	Ewing Sarcoma Of Bone	Teprotumumab
chr9	77794572	GNAQ T>G	GNAQ	T>G	604	Q209P	8923	Skin Melanoma	PLX4720
chr9	77794572	GNAQ T>G	GNAQ	T>G	604	Q209P	8923	Skin Melanoma	Vemurafenib
chr9	130862943	ABL1 A>G	ABL1	A>G	4597	M244V	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130862943	ABL1 A>G	ABL1	A>G	4597	M244V	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130862943	ABL1 A>G	ABL1	A>G	4597	M244V	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130862943	ABL1 A>G	ABL1	A>G	4597	M244V	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130862943	ABL1 A>G	ABL1	A>G	4597	M244V	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130862943	ABL1 A>G	ABL1	A>G	4597	M244V	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130862943	ABL1 A>G	ABL1	A>G	4597	M244V	8552	Chronic Myeloid Leukemia	Bafetinib
chr9	130862955	ABL1 C>G	ABL1	C>G	4632	L248V	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130862955	ABL1 C>G	ABL1	C>G	4632	L248V	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130862955	ABL1 C>G	ABL1	C>G	4632	L248V	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130862955	ABL1 C>G	ABL1	C>G	4632	L248V	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130862955	ABL1 C>G	ABL1	C>G	4632	L248V	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130862955	ABL1 C>G	ABL1	C>G	4632	L248V	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130862956	ABL1 T>G	ABL1	T>G	2340	L248R	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130862956	ABL1 T>G	ABL1	T>G	2340	L248R	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130862956	ABL1 T>G	ABL1	T>G	2340	L248R	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130862962	ABL1 G>A	ABL1	G>A	1023	G250E	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130862962	ABL1 G>A	ABL1	G>A	1023	G250E	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130862962	ABL1 G>A	ABL1	G>A	1023	G250E	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130862962	ABL1 G>A	ABL1	G>A	1023	G250E	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130862962	ABL1 G>A	ABL1	G>A	1023	G250E	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130862962	ABL1 G>A	ABL1	G>A	1023	G250E	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130862962	ABL1 G>A	ABL1	G>A	1023	G250E	8552	Chronic Myeloid Leukemia	Bafetinib
chr9	130862969	ABL1 G>C	ABL1	G>C	4634	Q252H	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130862969	ABL1 G>C	ABL1	G>C	4634	Q252H	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130862969	ABL1 G>C	ABL1	G>C	4634	Q252H	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130862969	ABL1 G>C	ABL1	G>C	4634	Q252H	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130862969	ABL1 G>C	ABL1	G>C	4634	Q252H	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130862969	ABL1 G>C	ABL1	G>C	4634	Q252H	8552	Chronic Myeloid Leukemia	Bafetinib
chr9	130862970	ABL1 T>C	ABL1	T>C	4529	Y253H	9952	Acute Lymphoblastic Leukemia	Bosutinib
chr9	130862970	ABL1 T>C	ABL1	T>C	4529	Y253H	9952	Acute Lymphoblastic Leukemia	Dasatinib
chr9	130862970	ABL1 T>C	ABL1	T>C	4529	Y253H	9952	Acute Lymphoblastic Leukemia	Imatinib Mesylate
chr9	130862970	ABL1 T>C	ABL1	T>C	4529	Y253H	9952	Acute Lymphoblastic Leukemia	Nilotinib
chr9	130862970	ABL1 T>C	ABL1	T>C	4529	Y253H	9952	Acute Lymphoblastic Leukemia	Axitinib
chr9	130862976	ABL1 G>A	ABL1	G>A	3	E255K	9952	Acute Lymphoblastic Leukemia	Bosutinib
chr9	130862976	ABL1 G>A	ABL1	G>A	3	E255K	9952	Acute Lymphoblastic Leukemia	Imatinib
chr9	130862976	ABL1 G>A	ABL1	G>A	3	E255K	9952	Acute Lymphoblastic Leukemia	Ponatinib
chr9	130862976	ABL1 G>A	ABL1	G>A	3	E255K	9952	Acute Lymphoblastic Leukemia	Imatinib Mesylate
chr9	130862976	ABL1 G>A	ABL1	G>A	3	E255K	9952	Acute Lymphoblastic Leukemia	Nilotinib
chr9	130862976	ABL1 G>A	ABL1	G>A	3	E255K	9952	Acute Lymphoblastic Leukemia	Dasatinib
chr9	130862976	ABL1 G>A	ABL1	G>A	3	E255K	9952	Acute Lymphoblastic Leukemia	Axitinib
chr9	130862977	ABL1 A>T	ABL1	A>T	4606	E255V	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130862977	ABL1 A>T	ABL1	A>T	4606	E255V	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130862977	ABL1 A>T	ABL1	A>T	4606	E255V	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130862977	ABL1 A>T	ABL1	A>T	4606	E255V	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130862977	ABL1 A>T	ABL1	A>T	4606	E255V	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130862977	ABL1 A>T	ABL1	A>T	4606	E255V	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130872133	ABL1 A>G	ABL1	A>G	4218	D276G	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130872133	ABL1 A>G	ABL1	A>G	4218	D276G	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130872133	ABL1 A>G	ABL1	A>G	4218	D276G	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130872133	ABL1 A>G	ABL1	A>G	4218	D276G	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130872133	ABL1 A>G	ABL1	A>G	4218	D276G	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130872133	ABL1 A>G	ABL1	A>G	4218	D276G	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130872141	ABL1 G>A	ABL1	G>A	1526	E279K	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130872141	ABL1 G>A	ABL1	G>A	1526	E279K	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130872171	ABL1 G>A	ABL1	G>A	1604	V289I	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130872181	ABL1 A>T	ABL1	A>T	1183	E292V	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130872198	ABL1 C>G	ABL1	C>G	1506	L298V	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130872201	ABL1 G>C	ABL1	G>C	4639	V299L	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130872201	ABL1 G>C	ABL1	G>C	4639	V299L	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130872201	ABL1 G>C	ABL1	G>C	4639	V299L	8552	Chronic Myeloid Leukemia	Ponatinib
chr9	130872201	ABL1 G>C	ABL1	G>C	4639	V299L	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130872201	ABL1 G>C	ABL1	G>C	4639	V299L	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130872201	ABL1 G>C	ABL1	G>C	4639	V299L	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130872205	ABL1 A>G	ABL1	A>G	1527	Q300R	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130872205	ABL1 A>G	ABL1	A>G	1527	Q300R	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130872883	ABL1 T>C	ABL1	T>C	1528	F311L	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130872883	ABL1 T>C	ABL1	T>C	1528	F311L	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130872883	ABL1 T>C	ABL1	T>C	1528	F311L	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130872883	ABL1 T>A	ABL1	T>A	1507	F311I	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130872896	ABL1 AC>GT	ABL1	AC>GT	2885	T315V	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130872895	ABL1 A>G	ABL1	A>G	4645	T315A	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130872895	ABL1 A>G	ABL1	A>G	4645	T315A	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130872895	ABL1 A>G	ABL1	A>G	4645	T315A	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130872895	ABL1 A>G	ABL1	A>G	4645	T315A	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130872895	ABL1 A>G	ABL1	A>G	4645	T315A	8552	Chronic Myeloid Leukemia	Bafetinib
chr9	130872896	ABL1 C>T	ABL1	C>T	2	T315I	9952	Acute Lymphoblastic Leukemia	Bosutinib
chr9	130872896	ABL1 C>T	ABL1	C>T	2	T315I	9952	Acute Lymphoblastic Leukemia	Imatinib
chr9	130872896	ABL1 C>T	ABL1	C>T	2	T315I	9952	Acute Lymphoblastic Leukemia	Ponatinib
chr9	130872896	ABL1 C>T	ABL1	C>T	2	T315I	9952	Acute Lymphoblastic Leukemia	Imatinib Mesylate
chr9	130872896	ABL1 C>T	ABL1	C>T	2	T315I	9952	Acute Lymphoblastic Leukemia	Nilotinib
chr9	130872896	ABL1 C>T	ABL1	C>T	2	T315I	9952	Acute Lymphoblastic Leukemia	Bafetinib
chr9	130872896	ABL1 C>T	ABL1	C>T	2	T315I	9952	Acute Lymphoblastic Leukemia	Dasatinib
chr9	130872896	ABL1 C>T	ABL1	C>T	2	T315I	9952	Acute Lymphoblastic Leukemia	Axitinib
chr9	130872901	ABL1 T>A	ABL1	T>A	1625	F317I	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130872901	ABL1 T>G	ABL1	T>G	1525	F317V	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130872901	ABL1 T>G	ABL1	T>G	1525	F317V	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130872901	ABL1 T>G	ABL1	T>G	1525	F317V	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130872901	ABL1 T>G	ABL1	T>G	1525	F317V	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130872901	ABL1 T>G	ABL1	T>G	1525	F317V	8552	Chronic Myeloid Leukemia	Bafetinib
chr9	130872902	ABL1 T>G	ABL1	T>G	2359	F317C	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130872902	ABL1 T>C	ABL1	T>C	2343	F317S	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130872903	ABL1 C>G	ABL1	C>G	1028	F317L	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130872903	ABL1 C>G	ABL1	C>G	1028	F317L	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130872903	ABL1 C>G	ABL1	C>G	1028	F317L	8552	Chronic Myeloid Leukemia	Ponatinib
chr9	130872903	ABL1 C>G	ABL1	C>G	1028	F317L	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130872903	ABL1 C>G	ABL1	C>G	1028	F317L	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130872903	ABL1 C>G	ABL1	C>G	1028	F317L	8552	Chronic Myeloid Leukemia	Bafetinib
chr9	130872903	ABL1 C>G	ABL1	C>G	1028	F317L	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130872903	ABL1 C>G	ABL1	C>G	1028	F317L	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130872914	ABL1 GG>CT	ABL1	GG>CT	1657	G340L	3908	Lung Non-small Cell Carcinoma	Imatinib Mesylate
chr9	130872914	ABL1 GG>CT	ABL1	GG>CT	1657	G340L	3908	Lung Non-small Cell Carcinoma	Dasatinib
chr9	130872944	ABL1 A>G	ABL1	A>G	1529	N331S	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130872946	ABL1 C>T	ABL1	C>T	1656	R351W	3908	Lung Non-small Cell Carcinoma	Imatinib
chr9	130872946	ABL1 C>T	ABL1	C>T	1656	R351W	3908	Lung Non-small Cell Carcinoma	Dasatinib
chr9	130872959	ABL1 A>G	ABL1	A>G	1640	N336S	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130872959	ABL1 A>G	ABL1	A>G	1640	N336S	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130872980	ABL1 T>C	ABL1	T>C	1524	M343T	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130873004	ABL1 T>C	ABL1	T>C	1029	M351T	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130873004	ABL1 T>C	ABL1	T>C	1029	M351T	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130873004	ABL1 T>C	ABL1	T>C	1029	M351T	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130873004	ABL1 T>C	ABL1	T>C	1029	M351T	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130873004	ABL1 T>C	ABL1	T>C	1029	M351T	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130873004	ABL1 T>C	ABL1	T>C	1029	M351T	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130873004	ABL1 T>C	ABL1	T>C	1029	M351T	8552	Chronic Myeloid Leukemia	Bafetinib
chr9	130873016	ABL1 A>G	ABL1	A>G	4609	E355G	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130873016	ABL1 A>G	ABL1	A>G	4609	E355G	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130873016	ABL1 A>G	ABL1	A>G	4609	E355G	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130873016	ABL1 A>G	ABL1	A>G	4609	E355G	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130873027	ABL1 T>A	ABL1	T>A	4607	F359I	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130873027	ABL1 T>A	ABL1	T>A	4607	F359I	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130873027	ABL1 T>A	ABL1	T>A	4607	F359I	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130873027	ABL1 T>A	ABL1	T>A	4607	F359I	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130873027	ABL1 T>G	ABL1	T>G	4598	F359V	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130873027	ABL1 T>G	ABL1	T>G	4598	F359V	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130873027	ABL1 T>G	ABL1	T>G	4598	F359V	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130873027	ABL1 T>G	ABL1	T>G	4598	F359V	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130873027	ABL1 T>G	ABL1	T>G	4598	F359V	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130873027	ABL1 T>G	ABL1	T>G	4598	F359V	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130873028	ABL1 T>G	ABL1	T>G	4610	F359C	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130873028	ABL1 T>G	ABL1	T>G	4610	F359C	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130873028	ABL1 T>G	ABL1	T>G	4610	F359C	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130873028	ABL1 T>G	ABL1	T>G	4610	F359C	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130874872	ABL1 C>A	ABL1	C>A	1508	L364I	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130874872	ABL1 C>A	ABL1	C>A	1508	L364I	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130874873	ABL1 T>C	ABL1	T>C	1530	L364P	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130874917	ABL1 G>A	ABL1	G>A	1609	V379I	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130874917	ABL1 G>A	ABL1	G>A	1609	V379I	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130874932	ABL1 C>A	ABL1	C>A	1230	L384M	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130874932	ABL1 C>A	ABL1	C>A	1230	L384M	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130874932	ABL1 C>A	ABL1	C>A	1230	L384M	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130874932	ABL1 C>A	ABL1	C>A	1230	L384M	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130874941	ABL1 T>A	ABL1	T>A	1488	L387M	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130874943	ABL1 G>C	ABL1	G>C	1232	L387F	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130874943	ABL1 G>C	ABL1	G>C	1232	L387F	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130874943	ABL1 G>C	ABL1	G>C	1232	L387F	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130874944	ABL1 A>T	ABL1	A>T	1610	M388L	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130874969	ABL1 A>G	ABL1	A>G	4611	H396R	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130874969	ABL1 A>G	ABL1	A>G	4611	H396R	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130874969	ABL1 A>G	ABL1	A>G	4611	H396R	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130874969	ABL1 A>G	ABL1	A>G	4611	H396R	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130874969	ABL1 A>G	ABL1	A>G	4611	H396R	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130874969	ABL1 A>C	ABL1	A>C	1531	H396P	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130874969	ABL1 A>C	ABL1	A>C	1531	H396P	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130874969	ABL1 A>C	ABL1	A>C	1531	H396P	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130874969	ABL1 A>C	ABL1	A>C	1531	H396P	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130874969	ABL1 A>C	ABL1	A>C	1531	H396P	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130874969	ABL1 A>C	ABL1	A>C	1531	H396P	8552	Chronic Myeloid Leukemia	Axitinib
chr9	130874969	ABL1 A>C	ABL1	A>C	1531	H396P	8552	Chronic Myeloid Leukemia	Bafetinib
chr9	130874971	ABL1 G>C	ABL1	G>C	4636	A397P	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130874971	ABL1 G>C	ABL1	G>C	4636	A397P	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130874974	ABL1 G>C	ABL1	G>C	1233	G398R	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130874974	ABL1 G>C	ABL1	G>C	1233	G398R	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130875032	ABL1 C>A	ABL1	C>A	1613	S417Y	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130875044	ABL1 A>G	ABL1	A>G	4638	D421G	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130878457	ABL1 C>G	ABL1	C>G	1495	S438C	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130878492	ABL1 G>C	ABL1	G>C	1618	E450Q	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130878493	ABL1 A>T	ABL1	A>T	1534	E450V	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130878501	ABL1 G>A	ABL1	G>A	1535	E453K	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130878501	ABL1 G>C	ABL1	G>C	1509	E453Q	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130878502	ABL1 A>C	ABL1	A>C	1536	E453A	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130878502	ABL1 A>C	ABL1	A>C	1536	E453A	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130878519	ABL1 G>A	ABL1	G>A	2370	E459K	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130878519	ABL1 G>A	ABL1	G>A	2370	E459K	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130878519	ABL1 G>A	ABL1	G>A	2370	E459K	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130880082	ABL1 C>G	ABL1	C>G	1537	P480A	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Axitinib
chr9	132896546	TSC1 G>A	TSC1	G>A	714	R1062W	13515	Tuberous Sclerosis	""
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Axitinib
chr9	136496409	NOTCH1 G>TGT	NOTCH1	G>TGT	137	V2444FS	3908	Lung Non-small Cell Carcinoma	""
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Axitinib
chr9	136496760	NOTCH1 G>A	NOTCH1	G>A	136	R2327W	3908	Lung Non-small Cell Carcinoma	""
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Axitinib
chr9	136504767	NOTCH1 C>G	NOTCH1	C>G	135	D1642H	3908	Lung Non-small Cell Carcinoma	""
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Bosutinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Imatinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Dasatinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Imatinib Mesylate
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Nilotinib
chr9	130880101	ABL1 T>C	ABL1	T>C	4635	F486S	8552	Chronic Myeloid Leukemia	Axitinib
chrX	47566722	ARAF C>G	ARAF	C>G	10	S214C	3908	Lung Non-small Cell Carcinoma	Sorafenib
chrX	47566722	ARAF C>G	ARAF	C>G	10	S214C	3908	Lung Non-small Cell Carcinoma	Trametinib
chrX	47569941	ARAF T>A	ARAF	T>A	825	S490T	9256	Colorectal Cancer	Cetuximab
chrX	47569941	ARAF T>A	ARAF	T>A	825	S490T	9256	Colorectal Cancer	Irinotecan
chrX	47569941	ARAF T>A	ARAF	T>A	825	S490T	9256	Colorectal Cancer	Vemurafenib
chrX	67723707	AR T>C	AR	T>C	175	F877L	10283	Prostate Cancer	Apalutamide
chrX	67723707	AR T>C	AR	T>C	175	F877L	10283	Prostate Cancer	Enzalutamide
chrX	101356177	BTK A>T	BTK	A>T	168	C481S	1040	Chronic Lymphocytic Leukemia	Ibrutinib
chrX	101358645	BTK T>C	BTK	T>C	870	T316A	1040	Chronic Lymphocytic Leukemia	Ibrutinib
chr10	43113622	RET G>A	RET	G>A	1260	C609Y	3973	Medullary Thyroid Carcinoma	""
chrX	101358645	BTK T>C	BTK	T>C	870	T316A	1040	Chronic Lymphocytic Leukemia	Ibrutinib
chr10	43114502	RET C>G	RET	C>G	112	C634W	3973	Medullary Thyroid Carcinoma	Motesanib
chr10	43121968	RET T>C	RET	T>C	113	M918T	3973	Medullary Thyroid Carcinoma	Sorafenib
chr10	43121968	RET T>C	RET	T>C	113	M918T	3973	Medullary Thyroid Carcinoma	Motesanib
chr10	43121968	RET T>C	RET	T>C	113	M918T	3973	Medullary Thyroid Carcinoma	JAK2 Inhibitor AZD1480
chr10	43121968	RET T>C	RET	T>C	113	M918T	3973	Medullary Thyroid Carcinoma	Cabozantinib
chr10	87933147	PTEN C>T	PTEN	C>T	636	R130*	1781	Thyroid Cancer	Temsirolimus
chr10	87933147	PTEN C>T	PTEN	C>T	636	R130*	1781	Thyroid Cancer	Perifosine
chr10	87952142	PTEN C>T	PTEN	C>T	838	R173C	0080191	PTEN Hamartoma Tumor Syndrome	""
chr10	87933147	PTEN C>T	PTEN	C>T	636	R130*	1781	Thyroid Cancer	Temsirolimus
chr10	87933147	PTEN C>T	PTEN	C>T	636	R130*	1781	Thyroid Cancer	Perifosine
chr10	87957915	PTEN C>T	PTEN	C>T	110	R233*	1612	Breast Cancer	MTOR Inhibitor
chr10	103090726	NT5C2 G>A	NT5C2	G>A	2897	S445F	0080144	Childhood Acute Lymphocytic Leukemia	Gemcitabine
chr10	103090726	NT5C2 G>A	NT5C2	G>A	2897	S445F	0080144	Childhood Acute Lymphocytic Leukemia	Cytarabine
chr10	103090726	NT5C2 G>A	NT5C2	G>A	2897	S445F	0080144	Childhood Acute Lymphocytic Leukemia	Thioguanine
chr10	103090726	NT5C2 G>A	NT5C2	G>A	2897	S445F	0080144	Childhood Acute Lymphocytic Leukemia	Doxorubicin
chr10	103090726	NT5C2 G>A	NT5C2	G>A	2897	S445F	0080144	Childhood Acute Lymphocytic Leukemia	Prednisolone
chr10	103090726	NT5C2 G>A	NT5C2	G>A	2897	S445F	0080144	Childhood Acute Lymphocytic Leukemia	Mercaptopurine
chr10	103090988	NT5C2 T>G	NT5C2	T>G	240	D407A	5603	T-cell Acute Lymphoblastic Leukemia	Nelarabine
chr10	103090988	NT5C2 T>G	NT5C2	T>G	240	D407A	5603	T-cell Acute Lymphoblastic Leukemia	Arabinosylguanine
chr10	103090988	NT5C2 T>G	NT5C2	T>G	240	D407A	5603	T-cell Acute Lymphoblastic Leukemia	Thioguanine
chr10	103090988	NT5C2 T>G	NT5C2	T>G	240	D407A	5603	T-cell Acute Lymphoblastic Leukemia	Mercaptopurine
chr10	103093198	NT5C2 C>T	NT5C2	C>T	238	R367Q	5603	T-cell Acute Lymphoblastic Leukemia	Prednisolone
chr10	103093198	NT5C2 C>T	NT5C2	C>T	238	R367Q	5603	T-cell Acute Lymphoblastic Leukemia	Arabinosylguanine
chr10	103093198	NT5C2 C>T	NT5C2	C>T	238	R367Q	5603	T-cell Acute Lymphoblastic Leukemia	Doxorubicin
chr10	103093198	NT5C2 C>T	NT5C2	C>T	238	R367Q	5603	T-cell Acute Lymphoblastic Leukemia	Mercaptopurine
chr10	103093198	NT5C2 C>T	NT5C2	C>T	238	R367Q	5603	T-cell Acute Lymphoblastic Leukemia	Nelarabine
chr10	103093198	NT5C2 C>T	NT5C2	C>T	238	R367Q	5603	T-cell Acute Lymphoblastic Leukemia	Cytarabine
chr10	103093198	NT5C2 C>T	NT5C2	C>T	238	R367Q	5603	T-cell Acute Lymphoblastic Leukemia	Thioguanine
chr10	103093198	NT5C2 C>T	NT5C2	C>T	238	R367Q	5603	T-cell Acute Lymphoblastic Leukemia	Gemcitabine
chr10	103093223	NT5C2 T>G	NT5C2	T>G	239	K359Q	9952	Acute Lymphoblastic Leukemia	Nelarabine
chr10	103093223	NT5C2 T>G	NT5C2	T>G	239	K359Q	9952	Acute Lymphoblastic Leukemia	Arabinosylguanine
chr10	103093223	NT5C2 T>G	NT5C2	T>G	239	K359Q	9952	Acute Lymphoblastic Leukemia	Thioguanine
chr10	103093223	NT5C2 T>G	NT5C2	T>G	239	K359Q	9952	Acute Lymphoblastic Leukemia	Mercaptopurine
chr10	103097350	NT5C2 G>A	NT5C2	G>A	2896	R238W	0080144	Childhood Acute Lymphocytic Leukemia	Gemcitabine
chr10	103097350	NT5C2 G>A	NT5C2	G>A	2896	R238W	0080144	Childhood Acute Lymphocytic Leukemia	Cytarabine
chr10	103097350	NT5C2 G>A	NT5C2	G>A	2896	R238W	0080144	Childhood Acute Lymphocytic Leukemia	Thioguanine
chr10	103097350	NT5C2 G>A	NT5C2	G>A	2896	R238W	0080144	Childhood Acute Lymphocytic Leukemia	Doxorubicin
chr10	103097350	NT5C2 G>A	NT5C2	G>A	2896	R238W	0080144	Childhood Acute Lymphocytic Leukemia	Prednisolone
chr10	103097350	NT5C2 G>A	NT5C2	G>A	2896	R238W	0080144	Childhood Acute Lymphocytic Leukemia	Mercaptopurine
chr10	121498520	FGFR2 A>T	FGFR2	A>T	545	N550K	1380	Endometrial Cancer	PD173074
chr10	129467281	MGMT C>T	MGMT	C>T	338	RS16906252	3068	Glioblastoma	Temozolomide
chr11	534285	HRAS C>T	HRAS	C>T	274	G13D	9256	Colorectal Cancer	Cetuximab
chr11	534285	HRAS C>T	HRAS	C>T	274	G13D	9256	Colorectal Cancer	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
chr11	534285	HRAS C>T	HRAS	C>T	274	G13D	9256	Colorectal Cancer	Vemurafenib
chr11	9578396	WEE1 A>G	WEE1	A>G	331	RS3910384	3908	Lung Non-small Cell Carcinoma	Platinum Compound
chr11	9578396	WEE1 A>G	WEE1	A>G	331	RS3910384	3908	Lung Non-small Cell Carcinoma	Gemcitabine
chr11	17720147	MYOD1 T>G	MYOD1	T>G	3032	L122R	3247	Rhabdomyosarcoma	""
chr11	9578396	WEE1 A>G	WEE1	A>G	331	RS3910384	3908	Lung Non-small Cell Carcinoma	Platinum Compound
chr11	9578396	WEE1 A>G	WEE1	A>G	331	RS3910384	3908	Lung Non-small Cell Carcinoma	Gemcitabine
chr11	67585218	GSTP1 A>G	GSTP1	A>G	259	I105V	9256	Colorectal Cancer	FOLFOX Regimen
chr11	108245002	ATM A>T	ATM	A>T	1155	K293*	1040	Chronic Lymphocytic Leukemia	Doxorubicin
chr11	108271404	ATM T>G	ATM	T>G	1158	F1025L	1040	Chronic Lymphocytic Leukemia	Doxorubicin
chr11	108299752	ATM G>C	ATM	G>C	1168	D1682H	1040	Chronic Lymphocytic Leukemia	Doxorubicin
chr11	108310186	ATM A>T	ATM	A>T	1160	D1930V	1040	Chronic Lymphocytic Leukemia	Doxorubicin
chr11	108316100	ATM C>T	ATM	C>T	1169	A2062V	1040	Chronic Lymphocytic Leukemia	Doxorubicin
chr11	108321407	ATM G>T	ATM	G>T	1162	E2187*	1040	Chronic Lymphocytic Leukemia	Doxorubicin
chr11	108329211	ATM T>C	ATM	T>C	1163	L2427P	1040	Chronic Lymphocytic Leukemia	Doxorubicin
chr11	108330369	ATM G>A	ATM	G>A	1172	C2488Y	1040	Chronic Lymphocytic Leukemia	Doxorubicin
chr11	108333954	ATM A>G	ATM	A>G	901	T2666A	1040	Chronic Lymphocytic Leukemia	Doxorubicin
chr11	108335887	ATM T>G	ATM	T>G	1164	F2732V	1040	Chronic Lymphocytic Leukemia	Doxorubicin
chr11	108347317	ATM A>C	ATM	A>C	244	N2875H	10283	Prostate Cancer	Olaparib
chr11	108365359	ATM C>T	ATM	C>T	903	R3008C	1040	Chronic Lymphocytic Leukemia	Doxorubicin
chr12	21176804	SLCO1B1 A>G	SLCO1B1	A>G	778	N130D	162	Cancer	Methotrexate
chr12	21178615	SLCO1B1 T>C	SLCO1B1	T>C	777	RS4149056	162	Cancer	Methotrexate
chr12	25207290	KRAS A>C	KRAS	A>C	254	RS61764370	2152	Epithelial Ovarian Cancer	Paclitaxel
chr12	25207290	KRAS A>C	KRAS	A>C	254	RS61764370	2152	Epithelial Ovarian Cancer	Carboplatin
chr12	25207290	KRAS A>C	KRAS	A>C	254	RS61764370	2152	Epithelial Ovarian Cancer	Cisplatin
chr12	25215520	KRAS C>T	KRAS	C>T	1207	R164Q	162	Cancer	""
chr12	25207290	KRAS A>C	KRAS	A>C	254	RS61764370	2152	Epithelial Ovarian Cancer	Paclitaxel
chr12	25207290	KRAS A>C	KRAS	A>C	254	RS61764370	2152	Epithelial Ovarian Cancer	Carboplatin
chr12	25207290	KRAS A>C	KRAS	A>C	254	RS61764370	2152	Epithelial Ovarian Cancer	Cisplatin
chr12	25225627	KRAS G>A	KRAS	G>A	322	A146V	9256	Colorectal Cancer	Dactolisib
chr12	25225627	KRAS G>A	KRAS	G>A	322	A146V	9256	Colorectal Cancer	Selumetinib
chr12	25225627	KRAS G>A	KRAS	G>A	322	A146V	9256	Colorectal Cancer	Abemaciclib
chr12	25225628	KRAS C>T	KRAS	C>T	906	A146T	9256	Colorectal Cancer	Cetuximab
chr12	25225628	KRAS C>T	KRAS	C>T	906	A146T	9256	Colorectal Cancer	Dactolisib
chr12	25225628	KRAS C>T	KRAS	C>T	906	A146T	9256	Colorectal Cancer	FOLFOX-4 Regimen
chr12	25225628	KRAS C>T	KRAS	C>T	906	A146T	9256	Colorectal Cancer	Selumetinib
chr12	25225628	KRAS C>G	KRAS	C>G	905	A146P	9256	Colorectal Cancer	Cetuximab
chr12	25225628	KRAS C>G	KRAS	C>G	905	A146P	9256	Colorectal Cancer	Irinotecan
chr12	25227341	KRAS T>G	KRAS	T>G	907	Q61H	9256	Colorectal Cancer	Cetuximab
chr12	25227341	KRAS T>G	KRAS	T>G	907	Q61H	9256	Colorectal Cancer	Chemotherapy
chr12	25227342	KRAS T>C	KRAS	T>C	909	Q61R	9256	Colorectal Cancer	Cetuximab
chr12	25227342	KRAS T>C	KRAS	T>C	909	Q61R	9256	Colorectal Cancer	Irinotecan
chr12	25227342	KRAS T>A	KRAS	T>A	908	Q61L	9256	Colorectal Cancer	Cetuximab
chr12	25227342	KRAS T>A	KRAS	T>A	908	Q61L	9256	Colorectal Cancer	Chemotherapy
chr12	25227343	KRAS G>T	KRAS	G>T	910	Q61K	9256	Colorectal Cancer	Cetuximab
chr12	25227343	KRAS G>T	KRAS	G>T	910	Q61K	9256	Colorectal Cancer	Chemotherapy
chr12	25245321	KRAS G>A	KRAS	G>A	479	Q22*	3029	Colon Mucinous Adenocarcinoma	Panitumumab
chr12	25245347	KRAS GC>AA	KRAS	GC>AA	1517	G13V	9256	Colorectal Cancer	Panitumumab
chr12	25245347	KRAS GC>AA	KRAS	GC>AA	1517	G13V	9256	Colorectal Cancer	Cetuximab
chr12	25245347	KRAS C>T	KRAS	C>T	81	G13D	1612	Breast Cancer	Cetuximab
chr12	25245347	KRAS C>T	KRAS	C>T	81	G13D	1612	Breast Cancer	Pictilisib
chr12	25245347	KRAS C>T	KRAS	C>T	81	G13D	1612	Breast Cancer	Panitumumab
chr12	25245347	KRAS C>T	KRAS	C>T	81	G13D	1612	Breast Cancer	Selumetinib
chr12	25245347	KRAS C>T	KRAS	C>T	81	G13D	1612	Breast Cancer	Regorafenib
chr12	25245347	KRAS C>T	KRAS	C>T	81	G13D	1612	Breast Cancer	Dactolisib
chr12	25245350	KRAS C>A	KRAS	C>A	425	G12V	9256	Colorectal Cancer	Palbociclib
chr12	25245350	KRAS C>A	KRAS	C>A	425	G12V	9256	Colorectal Cancer	Cetuximab
chr12	25245350	KRAS C>A	KRAS	C>A	425	G12V	9256	Colorectal Cancer	Crizotinib
chr12	25245350	KRAS C>A	KRAS	C>A	425	G12V	9256	Colorectal Cancer	Regorafenib
chr12	25245350	KRAS C>A	KRAS	C>A	425	G12V	9256	Colorectal Cancer	Dactolisib
chr12	25245350	KRAS C>A	KRAS	C>A	425	G12V	9256	Colorectal Cancer	Selumetinib
chr12	25245350	KRAS C>A	KRAS	C>A	425	G12V	9256	Colorectal Cancer	Gefitinib
chr12	25245350	KRAS C>A	KRAS	C>A	425	G12V	9256	Colorectal Cancer	Panitumumab
chr12	25245350	KRAS C>A	KRAS	C>A	425	G12V	9256	Colorectal Cancer	Docetaxel
chr12	25245350	KRAS C>G	KRAS	C>G	148	G12A	3910	Lung Adenocarcinoma	Melphalan
chr12	25245350	KRAS C>G	KRAS	C>G	148	G12A	3910	Lung Adenocarcinoma	Cetuximab
chr12	25245350	KRAS C>G	KRAS	C>G	148	G12A	3910	Lung Adenocarcinoma	Erlotinib
chr12	25245350	KRAS C>G	KRAS	C>G	148	G12A	3910	Lung Adenocarcinoma	Panitumumab
chr12	25245350	KRAS C>G	KRAS	C>G	148	G12A	3910	Lung Adenocarcinoma	Gefitinib
chr12	25245350	KRAS C>G	KRAS	C>G	148	G12A	3910	Lung Adenocarcinoma	Regorafenib
chr12	25245350	KRAS C>T	KRAS	C>T	79	G12D	9256	Colorectal Cancer	Melphalan
chr12	25245350	KRAS C>T	KRAS	C>T	79	G12D	9256	Colorectal Cancer	Dabrafenib
chr12	25245350	KRAS C>T	KRAS	C>T	79	G12D	9256	Colorectal Cancer	Vemurafenib
chr12	25245350	KRAS C>T	KRAS	C>T	79	G12D	9256	Colorectal Cancer	Therapeutic Tumor Infiltrating Lymphocytes
chr12	25245350	KRAS C>T	KRAS	C>T	79	G12D	9256	Colorectal Cancer	Cetuximab
chr12	25245350	KRAS C>T	KRAS	C>T	79	G12D	9256	Colorectal Cancer	Regorafenib
chr12	25245350	KRAS C>T	KRAS	C>T	79	G12D	9256	Colorectal Cancer	Dactolisib
chr12	25245350	KRAS C>T	KRAS	C>T	79	G12D	9256	Colorectal Cancer	Selumetinib
chr12	25245350	KRAS C>T	KRAS	C>T	79	G12D	9256	Colorectal Cancer	Gefitinib
chr12	25245350	KRAS C>T	KRAS	C>T	79	G12D	9256	Colorectal Cancer	Panitumumab
chr12	25245350	KRAS C>T	KRAS	C>T	79	G12D	9256	Colorectal Cancer	Akt Inhibitor MK2206
chr12	25245351	KRAS C>T	KRAS	C>T	913	G12S	9256	Colorectal Cancer	Cetuximab
chr12	25245351	KRAS C>T	KRAS	C>T	913	G12S	9256	Colorectal Cancer	Melphalan
chr12	25245351	KRAS C>T	KRAS	C>T	913	G12S	9256	Colorectal Cancer	Panitumumab
chr12	25245351	KRAS C>T	KRAS	C>T	913	G12S	9256	Colorectal Cancer	Gefitinib
chr12	25245351	KRAS C>T	KRAS	C>T	913	G12S	9256	Colorectal Cancer	Regorafenib
chr12	25245351	KRAS C>G	KRAS	C>G	530	G12R	9256	Colorectal Cancer	Panitumumab
chr12	25245351	KRAS C>G	KRAS	C>G	530	G12R	9256	Colorectal Cancer	Chemotherapy
chr12	25245351	KRAS C>G	KRAS	C>G	530	G12R	9256	Colorectal Cancer	Cetuximab
chr12	25245351	KRAS C>G	KRAS	C>G	530	G12R	9256	Colorectal Cancer	Regorafenib
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Melphalan
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Adagrasib
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Divarasib
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Sotorasib
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	ARS-853
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Cetuximab
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Chemotherapy
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Regorafenib
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Erlotinib
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Panitumumab
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Gefitinib
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Selumetinib
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Docetaxel
chr12	25245351	KRAS C>A	KRAS	C>A	78	G12C	9256	Colorectal Cancer	Dactolisib
chr12	56085067	ERBB3 C>G	ERBB3	C>G	702	R103G	2671	Transitional Cell Carcinoma	Afatinib
chr12	56085070	ERBB3 G>A	ERBB3	G>A	701	V104M	2671	Transitional Cell Carcinoma	Afatinib
chr12	56088138	ERBB3 G>A	ERBB3	G>A	703	G284R	2671	Transitional Cell Carcinoma	Afatinib
chr12	56097888	ERBB3 T>C	ERBB3	T>C	781	V855A	3908	Lung Non-small Cell Carcinoma	Afatinib
chr12	56097888	ERBB3 T>C	ERBB3	T>C	781	V855A	3908	Lung Non-small Cell Carcinoma	Pertuzumab
chr12	57751648	CDK4 G>A	CDK4	G>A	556	R24C	8923	Skin Melanoma	Palbociclib
chr12	68808800	MDM2 T>G	MDM2	T>G	495	SNP309	11934	Head And Neck Cancer	""
chr12	57751648	CDK4 G>A	CDK4	G>A	556	R24C	8923	Skin Melanoma	Palbociclib
chr12	111446804	SH2B3 T>C	SH2B3	T>C	699	RS3184504	9256	Colorectal Cancer	""
chr12	57751648	CDK4 G>A	CDK4	G>A	556	R24C	8923	Skin Melanoma	Palbociclib
chr13	28018504	FLT3 T>A	FLT3	T>A	1302	D835V	9119	Acute Myeloid Leukemia	AS602868
chr13	28018504	FLT3 T>A	FLT3	T>A	1302	D835V	9119	Acute Myeloid Leukemia	Cytarabine
chr13	28018504	FLT3 T>A	FLT3	T>A	1302	D835V	9119	Acute Myeloid Leukemia	Daunorubicin
chr13	28018504	FLT3 T>A	FLT3	T>A	1302	D835V	9119	Acute Myeloid Leukemia	Gilteritinib
chr13	28018504	FLT3 T>A	FLT3	T>A	1302	D835V	9119	Acute Myeloid Leukemia	Sunitinib
chr13	28018504	FLT3 T>A	FLT3	T>A	1302	D835V	9119	Acute Myeloid Leukemia	Quizartinib
chr13	28018504	FLT3 T>A	FLT3	T>A	1302	D835V	9119	Acute Myeloid Leukemia	Tyrphostin AG 1296
chr13	28018504	FLT3 T>A	FLT3	T>A	1302	D835V	9119	Acute Myeloid Leukemia	Tandutinib
chr13	28018505	FLT3 C>A	FLT3	C>A	3011	D835Y	9119	Acute Myeloid Leukemia	Sorafenib
chr13	28018505	FLT3 C>A	FLT3	C>A	3011	D835Y	9119	Acute Myeloid Leukemia	Gilteritinib
chr13	28018505	FLT3 C>G/A	FLT3	C>G/A	613	D835H/Y	9119	Acute Myeloid Leukemia	Sorafenib
chr13	28018505	FLT3 C>G	FLT3	C>G	612	D835H	9119	Acute Myeloid Leukemia	Sorafenib
chr13	28018505	FLT3 C>G	FLT3	C>G	612	D835H	9119	Acute Myeloid Leukemia	Gilteritinib
chr13	28050157	FLT3 G>A	FLT3	G>A	540	T227M	4450	Renal Cell Carcinoma	Sunitinib
chr13	32316462	BRCA2 T>G	BRCA2	T>G	1247	M1R	2394	Ovarian Cancer	Rucaparib
chr13	32316463	BRCA2 G>T	BRCA2	G>T	1248	M1I	2394	Ovarian Cancer	Rucaparib
chr13	32326150	BRCA2 G>A	BRCA2	G>A	1249	V159M	2394	Ovarian Cancer	Rucaparib
chr13	32326614	BRCA2 G>A	BRCA2	G>A	1251	V211I	2394	Ovarian Cancer	Rucaparib
chr13	32326614	BRCA2 G>C	BRCA2	G>C	1250	V211L	2394	Ovarian Cancer	Rucaparib
chr13	32346896	BRCA2 G>C	BRCA2	G>C	1252	R2336P	2394	Ovarian Cancer	Rucaparib
chr13	32394717	BRCA2 C>A	BRCA2	C>A	661	D3095E	1612	Breast Cancer	""
chr13	32346896	BRCA2 G>C	BRCA2	G>C	1252	R2336P	2394	Ovarian Cancer	Rucaparib
chr13	102845848	ERCC5 A>G	ERCC5	A>G	255	RS751402	0050903	Parietal Lobe Ependymoma	""
chr13	32346896	BRCA2 G>C	BRCA2	G>C	1252	R2336P	2394	Ovarian Cancer	Rucaparib
chr14	61747130	HIF1A T>C	HIF1A	T>C	433	3'	4074	Pancreatic Adenocarcinoma	""
chr13	32346896	BRCA2 G>C	BRCA2	G>C	1252	R2336P	2394	Ovarian Cancer	Rucaparib
chr14	64986345	FNTB G>C	FNTB	G>C	332	RS11623866	2394	Ovarian Cancer	Lonafarnib
chr14	95091293	DICER1 C>G	DICER1	C>G	2052	E1813Q	2997	Sertoli-Leydig Cell Tumor	""
chr14	64986345	FNTB G>C	FNTB	G>C	332	RS11623866	2394	Ovarian Cancer	Lonafarnib
chr14	95094139	DICER1 C>T	DICER1	C>T	2050	E1705K	2997	Sertoli-Leydig Cell Tumor	""
chr14	64986345	FNTB G>C	FNTB	G>C	332	RS11623866	2394	Ovarian Cancer	Lonafarnib
chr14	104776711	AKT1 G>T	AKT1	G>T	169	Q79K	1909	Melanoma	Dabrafenib
chr14	104776711	AKT1 G>T	AKT1	G>T	169	Q79K	1909	Melanoma	Vemurafenib
chr14	104780214	AKT1 C>T	AKT1	C>T	4	E17K	1612	Breast Cancer	Uprosertib
chr14	104780214	AKT1 C>T	AKT1	C>T	4	E17K	1612	Breast Cancer	Capivasertib
chr14	104780214	AKT1 C>T	AKT1	C>T	4	E17K	1612	Breast Cancer	Akt Inhibitor MK2206
chr14	104780214	AKT1 C>T	AKT1	C>T	4	E17K	1612	Breast Cancer	Vemurafenib
chr15	66435113	MAP2K1 A>C	MAP2K1	A>C	83	Q56P	1909	Melanoma	Selumetinib
chr15	66435117	MAP2K1 G>T	MAP2K1	G>T	1272	K57N	3910	Lung Adenocarcinoma	Selumetinib
chr15	66436816	MAP2K1 G>C	MAP2K1	G>C	627	C121S	1909	Melanoma	Vemurafenib
chr15	66436824	MAP2K1 C>T	MAP2K1	C>T	82	P124S	1909	Melanoma	Selumetinib
chr15	74022872	PML C>T	PML	C>T	462	A216V	0060318	Acute Promyelocytic Leukemia	Tretinoin
chr15	74022872	PML C>T	PML	C>T	462	A216V	0060318	Acute Promyelocytic Leukemia	Arsenic Trioxide
chr15	74022878	PML T>C	PML	T>C	463	L218P	0060318	Acute Promyelocytic Leukemia	Tretinoin
chr15	87933034	NTRK3 C>T	NTRK3	C>T	2691	G623R	162	Cancer	ALK/TRK Inhibitor TSR-011
chr15	87933034	NTRK3 C>T	NTRK3	C>T	2691	G623R	162	Cancer	Crizotinib
chr15	87933034	NTRK3 C>T	NTRK3	C>T	2691	G623R	162	Cancer	Repotrectinib
chr15	87933034	NTRK3 C>T	NTRK3	C>T	2691	G623R	162	Cancer	Larotrectinib
chr15	87933034	NTRK3 C>T	NTRK3	C>T	2691	G623R	162	Cancer	Entrectinib
chr15	90088606	IDH2 C>T	IDH2	C>T	63	R172K	9119	Acute Myeloid Leukemia	Vorasidenib
chr16	2080299	TSC2 C>T	TSC2	C>T	469	Q1178*	3963	Thyroid Gland Carcinoma	Everolimus
chr16	69711242	NQO1 G>A	NQO1	G>A	402	P187S	1324	Lung Cancer	Amrubicin
chr17	7673775	TP53 C>A	TP53	C>A	1108	R282L	5517	Stomach Carcinoma	EAP Protocol
chr17	7673793	TP53 G>A	TP53	G>A	1050	A276V			""
chr17	7673775	TP53 C>A	TP53	C>A	1108	R282L	5517	Stomach Carcinoma	EAP Protocol
chr17	7673802	TP53 C>A	TP53	C>A	918	R273L	2394	Ovarian Cancer	Carboplatin
chr17	7673802	TP53 C>A	TP53	C>A	918	R273L	2394	Ovarian Cancer	Cisplatin
chr17	7673802	TP53 C>T	TP53	C>T	122	R273H	1612	Breast Cancer	MDM2 Inhibitor AMGMDS3
chr17	7673802	TP53 C>T	TP53	C>T	122	R273H	1612	Breast Cancer	Doxorubicin
chr17	7673802	TP53 C>T	TP53	C>T	122	R273H	1612	Breast Cancer	Methotrexate
chr17	7673803	TP53 G>A	TP53	G>A	121	R273C	1612	Breast Cancer	MDM2 Inhibitor AMGMDS3
chr17	7673803	TP53 G>A	TP53	G>A	121	R273C	1612	Breast Cancer	Etoposide
chr17	7673803	TP53 G>A	TP53	G>A	121	R273C	1612	Breast Cancer	Mitomycin
chr17	7673803	TP53 G>A	TP53	G>A	121	R273C	1612	Breast Cancer	Cisplatin
chr17	7674217	TP53 C>G	TP53	C>G	119	R249	1612	Breast Cancer	Doxorubicin
chr17	7674220	TP53 C>T	TP53	C>T	117	R248Q	1612	Breast Cancer	MDM2 Inhibitor AMGMDS3
chr17	7674221	TP53 G>A	TP53	G>A	118	R248W	1612	Breast Cancer	MDM2 Inhibitor AMGMDS3
chr17	7674230	TP53 C>T	TP53	C>T	879	G245S	162	Cancer	MDM2 Inhibitor AMGMDS3
chr17	7674238	TP53 C>T	TP53	C>T	1064	C242Y			""
chr17	7674230	TP53 C>T	TP53	C>T	879	G245S	162	Cancer	MDM2 Inhibitor AMGMDS3
chr17	7674250	TP53 C>T	TP53	C>T	2648	C238Y	1612	Breast Cancer	""
chr17	7674230	TP53 C>T	TP53	C>T	879	G245S	162	Cancer	MDM2 Inhibitor AMGMDS3
chr17	7674252	TP53 C>A	TP53	C>A	1066	M237I	3068	Glioblastoma	MDM2 Inhibitor AMGMDS3
chr17	7674262	TP53 T>C	TP53	T>C	1068	Y234C	2394	Ovarian Cancer	Carboplatin
chr17	7674262	TP53 T>C	TP53	T>C	1068	Y234C	2394	Ovarian Cancer	Cisplatin
chr17	7674872	TP53 T>C	TP53	T>C	922	Y220C	162	Cancer	MDM2 Inhibitor AMGMDS3
chr17	7674872	TP53 T>C	TP53	T>C	922	Y220C	162	Cancer	Etoposide
chr17	7674872	TP53 T>C	TP53	T>C	922	Y220C	162	Cancer	Mitomycin
chr17	7674872	TP53 T>C	TP53	T>C	922	Y220C	162	Cancer	Cisplatin
chr17	7674893	TP53 C>G	TP53	C>G	1109	R213P	5517	Stomach Carcinoma	EAP Protocol
chr17	7675088	TP53 C>T	TP53	C>T	116	R175H	1612	Breast Cancer	MDM2 Inhibitor AMGMDS3
chr17	7675088	TP53 C>T	TP53	C>T	116	R175H	1612	Breast Cancer	Doxorubicin
chr17	7675088	TP53 C>T	TP53	C>T	116	R175H	1612	Breast Cancer	EAP Protocol
chr17	7675131	TP53 C>T	TP53	C>T	1114	A161T			""
chr17	7675088	TP53 C>T	TP53	C>T	116	R175H	1612	Breast Cancer	MDM2 Inhibitor AMGMDS3
chr17	7675088	TP53 C>T	TP53	C>T	116	R175H	1612	Breast Cancer	Doxorubicin
chr17	7675088	TP53 C>T	TP53	C>T	116	R175H	1612	Breast Cancer	EAP Protocol
chr17	7675139	TP53 C>A	TP53	C>A	1699	R158L	162	Cancer	MDM2 Inhibitor AMGMDS3
chr17	7675139	TP53 C>T	TP53	C>T	1695	R158H	2101	Vulva Squamous Cell Carcinoma	MDM2 Inhibitor AMGMDS3
chr17	7675143	TP53 C>A	TP53	C>A	1092	V157F	162	Cancer	MDM2 Inhibitor AMGMDS3
chr17	7675207	TP53 G>C	TP53	G>C	924	C135W			""
chr17	7675143	TP53 C>A	TP53	C>A	1092	V157F	162	Cancer	MDM2 Inhibitor AMGMDS3
chr17	7676154	TP53 G>C	TP53	G>C	531	P72R	3905	Lung Carcinoma	""
chr17	7675143	TP53 C>A	TP53	C>A	1092	V157F	162	Cancer	MDM2 Inhibitor AMGMDS3
chr17	7676230	TP53 G>A	TP53	G>A	504	P47S	162	Cancer	Cisplatin
chr17	35106406	RAD51D G>A	RAD51D	G>A	471	R186*	1612	Breast Cancer	""
chr17	7676230	TP53 G>A	TP53	G>A	504	P47S	162	Cancer	Cisplatin
chr17	39711952	ERBB2 G>C	ERBB2	G>C	38	G309A	1612	Breast Cancer	Neratinib
chr17	39723405	ERBB2 G>A	ERBB2	G>A	42	R678Q	1612	Breast Cancer	Neratinib
chr17	39723405	ERBB2 G>A	ERBB2	G>A	42	R678Q	1612	Breast Cancer	Lapatinib
chr17	39723967	ERBB2 TT>CC	ERBB2	TT>CC	1304	L755P	3908	Lung Non-small Cell Carcinoma	Trastuzumab Deruxtecan
chr17	39723967	ERBB2 TT>CC	ERBB2	TT>CC	1304	L755P	3908	Lung Non-small Cell Carcinoma	Lapatinib
chr17	39723967	ERBB2 T>G	ERBB2	T>G	40	L755W	1612	Breast Cancer	Neratinib
chr17	39723967	ERBB2 T>C	ERBB2	T>C	39	L755S	0050861	Colorectal Adenocarcinoma	Leucovorin
chr17	39723967	ERBB2 T>C	ERBB2	T>C	39	L755S	0050861	Colorectal Adenocarcinoma	Fluorouracil
chr17	39723967	ERBB2 T>C	ERBB2	T>C	39	L755S	0050861	Colorectal Adenocarcinoma	Neratinib
chr17	39723967	ERBB2 T>C	ERBB2	T>C	39	L755S	0050861	Colorectal Adenocarcinoma	Lapatinib
chr17	39723967	ERBB2 T>C	ERBB2	T>C	39	L755S	0050861	Colorectal Adenocarcinoma	Trastuzumab
chr17	39724008	ERBB2 G>T	ERBB2	G>T	36	D769Y	1612	Breast Cancer	Neratinib
chr17	39724008	ERBB2 G>T	ERBB2	G>T	36	D769Y	1612	Breast Cancer	Afatinib
chr17	39724008	ERBB2 G>C	ERBB2	G>C	35	D769H	1612	Breast Cancer	Neratinib
chr17	39724008	ERBB2 G>C	ERBB2	G>C	35	D769H	1612	Breast Cancer	Lapatinib
chr17	39724736	ERBB2 T>C	ERBB2	T>C	872	V773A	162	Cancer	Lapatinib
chr17	39724738	ERBB2 A>TGGCTGG	ERBB2	A>TGGCTGG	818	M774DELINSWLV	3908	Lung Non-small Cell Carcinoma	Dacomitinib
chr17	39724745	ERBB2 GG>CT	ERBB2	GG>CT	816	G776L	3910	Lung Adenocarcinoma	Afatinib
chr17	39724747	ERBB2 G>T	ERBB2	G>T	44	V777L	1612	Breast Cancer	Neratinib
chr17	39724747	ERBB2 G>T	ERBB2	G>T	44	V777L	1612	Breast Cancer	Afatinib
chr17	39724747	ERBB2 G>T	ERBB2	G>T	44	V777L	1612	Breast Cancer	Lapatinib
chr17	39724747	ERBB2 G>T	ERBB2	G>T	44	V777L	1612	Breast Cancer	Trastuzumab
chr17	39724811	ERBB2 C>T	ERBB2	C>T	2331	T798I	1612	Breast Cancer	Osimertinib
chr17	39724812	ERBB2 CA>TG	ERBB2	CA>TG	1305	T798M	162	Cancer	Lapatinib
chr17	39725079	ERBB2 G>A	ERBB2	G>A	45	V842I	1612	Breast Cancer	Neratinib
chr17	39725079	ERBB2 G>A	ERBB2	G>A	45	V842I	1612	Breast Cancer	Trastuzumab
chr17	39725079	ERBB2 G>A	ERBB2	G>A	45	V842I	1612	Breast Cancer	Lapatinib
chr17	39725125	ERBB2 A>G	ERBB2	A>G	873	N857S	162	Cancer	Lapatinib
chr17	39725139	ERBB2 A>G	ERBB2	A>G	871	T862A	162	Cancer	Lapatinib
chr17	39725151	ERBB2 C>A	ERBB2	C>A	496	L866M	219	Colon Cancer	Neratinib
chr17	39725151	ERBB2 C>A	ERBB2	C>A	496	L866M	219	Colon Cancer	Trastuzumab
chr17	39725151	ERBB2 C>A	ERBB2	C>A	496	L866M	219	Colon Cancer	Lapatinib
chr17	39725187	ERBB2 C>T	ERBB2	C>T	874	H878Y	162	Cancer	Lapatinib
chr17	39725363	ERBB2 C>T	ERBB2	C>T	43	R896C	1612	Breast Cancer	Neratinib
chr17	43047665	BRCA1 C>T	BRCA1	C>T	1555	W1815X	5828	Endometrioid Ovary Carcinoma	Olaparib
chr17	43076573	BRCA1 G>A	BRCA1	G>A	1246	Q1467*	2394	Ovarian Cancer	Rucaparib
chr17	48728343	HOXB13 C>T	HOXB13	C>T	772	G84E	10283	Prostate Cancer	""
chr17	43076573	BRCA1 G>A	BRCA1	G>A	1246	Q1467*	2394	Ovarian Cancer	Rucaparib
chr17	76736877	SRSF2 G>T	SRSF2	G>T	4304	P95H	0070004	Myeloid Neoplasm	CTX-712
chr17	76736877	SRSF2 G>A	SRSF2	G>A	4303	P95L	0070004	Myeloid Neoplasm	CTX-712
chr18	44951948	SETBP1 G>A	SETBP1	G>A	351	G870S	8552	Chronic Myeloid Leukemia	""
chr17	76736877	SRSF2 G>A	SRSF2	G>A	4303	P95L	0070004	Myeloid Neoplasm	CTX-712
chr18	63318357	BCL2 A>T	BCL2	A>T	3082	F104I	0050873	Follicular Lymphoma	Venetoclax
chr18	63318365	BCL2 C>A	BCL2	C>A	2960	G101V	6354	Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma	Venetoclax
chr19	1220490	STK11 C>A	STK11	C>A	634	D194E	1793	Pancreatic Cancer	Everolimus
chr19	7910272	MAP2K7 G>A	MAP2K7	G>A	566	E116K	1324	Lung Cancer	""
chr19	1220490	STK11 C>A	STK11	C>A	634	D194E	1793	Pancreatic Cancer	Everolimus
chr19	43551574	XRCC1 T>C	XRCC1	T>C	261	Q399R	3908	Lung Non-small Cell Carcinoma	Carboplatin
chr19	43551574	XRCC1 T>C	XRCC1	T>C	261	Q399R	3908	Lung Non-small Cell Carcinoma	Cisplatin
chr19	43553422	XRCC1 G>A	XRCC1	G>A	249	R194W	3908	Lung Non-small Cell Carcinoma	Gemcitabine
chr19	43553422	XRCC1 G>A	XRCC1	G>A	249	R194W	3908	Lung Non-small Cell Carcinoma	Vinorelbine
chr19	43553422	XRCC1 G>A	XRCC1	G>A	249	R194W	3908	Lung Non-small Cell Carcinoma	Docetaxel
chr19	45351661	ERCC2 T>G	ERCC2	T>G	264	K751Q	3908	Lung Non-small Cell Carcinoma	Paclitaxel
chr19	45351661	ERCC2 T>G	ERCC2	T>G	264	K751Q	3908	Lung Non-small Cell Carcinoma	Carboplatin
chr19	45351661	ERCC2 T>G	ERCC2	T>G	264	K751Q	3908	Lung Non-small Cell Carcinoma	Cisplatin
chr19	48873985	PPP1R15A G>C	PPP1R15A	G>C	548	RS557806	9256	Colorectal Cancer	Bevacizumab
chr19	48873985	PPP1R15A G>C	PPP1R15A	G>C	548	RS557806	9256	Colorectal Cancer	FOLFIRI Regimen
chr20	58853658	GNAS T>C	GNAS	T>C	877	c.393T>C	9256	Colorectal Cancer	Fluorouracil
chr20	58853658	GNAS T>C	GNAS	T>C	877	c.393T>C	9256	Colorectal Cancer	Gefitinib
chr20	58853658	GNAS T>C	GNAS	T>C	877	c.393T>C	9256	Colorectal Cancer	Erlotinib
chr20	58853658	GNAS T>C	GNAS	T>C	877	c.393T>C	9256	Colorectal Cancer	Cisplatin
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Cetuximab
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Irinotecan
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Vemurafenib
chr21	34799407	RUNX1 G>T	RUNX1	G>T	803	Y260*	9119	Acute Myeloid Leukemia	""
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Cetuximab
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Irinotecan
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Vemurafenib
chr21	34859495	RUNX1 C>A	RUNX1	C>A	806	D198Y	9119	Acute Myeloid Leukemia	""
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Cetuximab
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Irinotecan
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Vemurafenib
chr21	34880665	RUNX1 C>G	RUNX1	C>G	807	A107P	9119	Acute Myeloid Leukemia	""
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Cetuximab
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Irinotecan
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Vemurafenib
chr21	34886866	RUNX1 T>C	RUNX1	T>C	802	K83E	9119	Acute Myeloid Leukemia	""
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Cetuximab
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Irinotecan
chr20	58909365	GNAS C>T	GNAS	C>T	826	R201C	9256	Colorectal Cancer	Vemurafenib
chr21	38819714	ETS2 A>G	ETS2	A>G	445	RS461155	3908	Lung Non-small Cell Carcinoma	Paclitaxel
chr21	38819714	ETS2 A>G	ETS2	A>G	445	RS461155	3908	Lung Non-small Cell Carcinoma	Cisplatin
chr21	43094667	U2AF1 T>G	U2AF1	T>G	127	Q157P/R	9119	Acute Myeloid Leukemia	""
chr21	38819714	ETS2 A>G	ETS2	A>G	445	RS461155	3908	Lung Non-small Cell Carcinoma	Paclitaxel
chr21	38819714	ETS2 A>G	ETS2	A>G	445	RS461155	3908	Lung Non-small Cell Carcinoma	Cisplatin
chr21	43104346	U2AF1 G>A	U2AF1	G>A	128	S34Y/F	9119	Acute Myeloid Leukemia	""
chr21	38819714	ETS2 A>G	ETS2	A>G	445	RS461155	3908	Lung Non-small Cell Carcinoma	Paclitaxel
chr21	38819714	ETS2 A>G	ETS2	A>G	445	RS461155	3908	Lung Non-small Cell Carcinoma	Cisplatin
chr22	21772875	MAPK1 C>T	MAPK1	C>T	320	E322K	5520	Head And Neck Squamous Cell Carcinoma	Erlotinib
chr22	28725099	CHEK2 A>G	CHEK2	A>G	787	I157T	10283	Prostate Cancer	""
chr22	21772875	MAPK1 C>T	MAPK1	C>T	320	E322K	5520	Head And Neck Squamous Cell Carcinoma	Erlotinib
